About This Report
This is the fourth Sustainability/ESG/Social Responsibility
Report disclosed by Zhonghong Pulin Medical Products Name abbreviations
Co. Ltd. Anchored in the core principles of standardization
transparency objectivity and comprehensiveness this For better expression and readability “Zhonghong Pulinreport aims to present to our stakeholders the Company’s Medical Products Co. Ltd.” in this report is referred to as
performance and outcomes in corporate governance “Zhonghong Medical” “the Company” or “we/our”.environmental protection and social welfare. We hope Subsidiaries involved in this report are:
this report will help foster a deeper understanding of our “Jiangxi Kelun Medical Devices Manufacturing Co. Ltd.”
sustainability philosophy and operational practices among referred to as “Kelun Medical Devices”;
our stakeholders. We remain steadfast in advancing our ESG “Jiangxi Zhonghong Pulin Medical Products Co. Ltd.”
initiatives continuously enhancing our corporate governance referred to as “Jiangxi Zhonghong”;
capabilities and driving high-quality efficient development. “Guilin HBM Health Protections Inc.” referred to as “GuilinHBM”;
Preparation basis “Shenzhen MedRena Biotech Co. Ltd.” referred to as “MedRena”.Branches involved in this report are:This report is prepared in accordance with the Self-Regulatory “Tangshan No.1 Branch of Zhonghong Pulin Medical ProductsGuidelines No. 2 for Companies Listed on Shenzhen Stock Co. Ltd.” referred to as “the First Tangshan Branch”;Exchange—Standardized Operation of Listed Companies on “Tangshan No.2 Branch of Zhonghong Pulin Medical Productsthe ChiNext Board the Self-Regulatory Guidelines No. 17 for Co. Ltd.” referred to as “the Second Tangshan Branch”;Companies Listed on Shenzhen Stock Exchange—Sustainability “Tangshan No.3 Branch of Zhonghong Pulin Medical ProductsReport (For Trial Implementation) and the Self-Regulatory Co. Ltd.” referred to as “the Third Tangshan Branch”;Guidance No. 3 for Companies Listed on the ChiNext Board “Tangshan No.5 Branch of Zhonghong Pulin Medical Productsof Shenzhen Stock Exchange—Preparation of Sustainability Co. Ltd.” referred to as “the Fifth Tangshan Branch”;Report and with reference to the UN Sustainable Development “Tangshan No.6 Branch of Zhonghong Pulin Medical ProductsGoals (SDGs) GRI Sustainability Reporting Standards (GRI Co. Ltd.” referred to as “the Sixth Tangshan Branch”;Standards) issued by Global Sustainability Standards Board “Tangshan Color Printing and Packaging Branch of(GSSB) and other relevant standards. It also draws on the ESG Zhonghong Pulin Medical Products Co. Ltd.” referred to as
topics required by Wind ESG rating. the “Color Printing and Packaging Branch”.Reporting scope Report access
Unless otherwise specified the information in this report You can download the Chinese and English versions of this
covers the period from January 1 2025 to December 31 report from Shenzhen Stock Exchange https://www.szse.cn/
2025. Some information may refer to earlier or later years as English/index.html In case of any discrepancy the Chinese
context requires. This report covers Zhonghong Pulin Medical version shall prevail.Products Co. Ltd. and its subsidiaries and branches.Feedback
Data source
Please scan the QR code to leave your feedback.Unless otherwise specified the data in this report are
sourced from the Company’s internal materials investigation
and interview records and other relevant documents. The
Board of Directors of the Company is responsible for the
authenticity accuracy and completeness of the report and
assures that it is free of false or misleading statements. The
currency used in this report is Chinese Renminbi (RMB).CONTENTS CONTENTS
01 About This Report 10 Sustainability Management
04 Message from the Chairman 14 Spotlight: Digital Future
06 About Zhonghong Medical Intelligent Healthcare
18 A Green Defining Feature 50 Responsibility First Guided
Worth Protection by Our Original Mission
20 Environmental Compliance 52 Healthcare Accessibility
Management 54 Win-Win Collaboration
22 Resource Conservation 55 Social Welfare Engagement
24 Waste and Pollution Control
25 Green Offices
26 Quality at Our Core and 56 Sound Governance for
Service with Craftsmanship Honest Operations
28 Innovation Drives Development 58 Governance Foundation
3 1 Reliable Products 59 Operational Compliance
34 Sustainable Supply Chain 6 1 Business Ethics
37 Premium Service
40 People-Centered Approach 63 Key Performance Table
for Unity and Strength 66 Indicator Indexes
42 Employee Rights Protection
45 Employee Growth
46 Occupational Health and Safety2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Message from the Chairman 04 05
Message from the Chairman“The year wanes yet a new chapter dawns.
2025 marked a year of determined progress for Zhonghong Medical as the Company stayed focused on its strategic
blueprint and built momentum for the next stage of growth. It was also a pivotal year to practice the philosophy of
“operations over management” and to shape the planning for the 15th Five-Year Plan period. We advanced our global
presence drove progress through technological innovation and grounded our actions in responsibility translating the
principles of sustainable development—coexisting with society harmonizing with the environment and advancing
with the times—into concrete practice.In 2025 Zhonghong Medical advanced in harmony with the environment.Green production is Zhonghong Medical’s sustainability foundation. Leveraging our five major domestic production bases
we continued to advance equipment automation and process optimization. While ensuring product quality we achieved
breakthroughs in both capacity expansion and cost reduction. Through initiatives such as energy conservation consumption
reduction and low-carbon production we strengthened the foundations of green manufacturing contributing to the global
green transition of the medical protection industry with efficient green operations.In 2025 Zhonghong Medical resonated with the society.We fulfill our social responsibilities through our commitment to the industry. In Chinese market we established partnerships
with over 700 new hospitals building an extensive marketing network that enables high-quality protective products to reach
more primary-level hospitals. Internationally our “self-development + M&A” global expansion strategy delivered solid results.Two overseas production bases progressed steadily while our business footprint expanded to over 100 countries and regions
worldwide earning global recognition for China’s medical protection technologies and quality.In 2025 Zhonghong Medical prospered with responsibilities.We safeguard long-term growth through excellent governance. The Company has diversified its stakeholder engagement
mechanism deeply integrating their needs into strategic decision-making and risk management contributing to a resilient
and robust industry ecosystem. During the reporting period the Company was honored as the Chair Unit of the Latex Branch
of China Rubber Industry Association. Through a standard internal control system with transparent information disclosure we
strengthened the institutional foundation for steady growth and set a benchmark for industry governance.Looking ahead guided by China’ 15th Five-Year Plan Zhonghong Medical will seize opportunities in global competition continue
to enhance its presence in the medical protection sector expand its global industry footprint and enhance international
competitiveness. With the goal of becoming a “forward-looking intelligent trusted and time-honored Zhonghong Medical” we
work to contribute more Chinese wisdom to global healthcare and to write a new chapter of high-quality development with
even greater achievements.Forge ahead with steadfast dedication and we will pursue lasting impact through practice.Chairman
Sang Shujun“2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report About Zhonghong Medical 06 07About Zhonghong Medical
Company Profile Our History
Zhonghong Pulin Medical Products Co. Ltd.(“Zhonghong Medical”) founded in 2010 2010-2014 2015-2020 2021
is a core member of Xiamen ITG Holding
Group Co. Ltd. (one of Fortune Global 500
companies). Focusing on the healthcare O ur company was founded. T he Sixth Tangshan Branch was established Continental Medical B.V. Z h o n g h o n g P u l i n
industry Zhonghong Medical is engaged in W e undertook the g love assets and and the first workshop started construction. was established. M e d i ca l P ro d u c t s
the research and development production businesses of Tangshan Zhonghong Pulin The Company was renamed as Zhonghong The Company started the Co. Ltd. was listed
and sa les of h igh-qual i ty d isposable Group Co. Ltd. including the First Tangshan Pulin Medical Products Co. Ltd. IPO declaration. on the ChiNext Board
health protection products medical sterile Branch the Second Tangshan Branch the The United Medical Inc was established. T he Company started of Shenzhen Stock
equipment comprehensive life support Third Tangshan Branch the Fifth Tangshan Jiangxi Zhonghong Pulin Medical Products construction of Jiangxi Exchange (SZSE).solutions and other medical consumables Branch as well as Tangshan Color Printing Co. Ltd. was established. Base Phase II.and equipment . Dur ing the report ing Packaging Branch. T he first phase project of Jiangxi Subsidiary was
period we had four business divisions ie started and the second phase project of the
Health Protection Safe Infusion Innovative Sixth Tangshan Branch was put into operation.Incubation International Development and
owns seven production bases worldwide
whose large-scale production capacity can 2023 2022
effectively guarantee stable supply and
continuous after-sales service support.We have developed a R&D system formed The Company acquired Shenzhen MedRena T he Company acquired Guilin HBM Health T he Company acquired Jiangxi Kelun Medical Devices Manufacturing Co.by Tangshan Research Institute Shanghai Biotech Co. Ltd. ProtectionsInc. to develop latex gloves and Ltd. to expand its business of safe infusion.Research Institute Yichun Research Institute condom products.Shenzhen Research Institute Guilin Research
Institute and Hainan Subsidiary. The Company
has been included into the List of State-
Owned Enterprises Selected for the "World-
Class Professional Leader" Cult ivation
Program. It ranks among China’s top 50
The Company established Beijing Zhonghong Zhonghong Medical Supplies (Hainan) Co. Ltd.(Hainan Subsidiary) was
medical device companies Top 500 Most
Pulin Reproductive Medical Technology Co. Ltd. established as a medical transformation and R&D platform.Valuable Chinese Brands and is recognized
as a national high-tech enterprise. Guilin 2024 2025
HBM is selected as a national specialized and
innovative "little giant" enterprise.W e held equity of Wismed Intell igent Acquisition of a 75% equity stake in Thailand's We signed a strategic cooperation agreement with EverBridge Group to
Technology (Beijing) Co. Ltd and work to Zoupure Medic Company marking the forge business in product R&D market expansion and technical services
establish a long-term and comprehensive Group's first overseas M&A transaction and etc.strategic partnership with it. accelerating the layout of overseas capital.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report About Zhonghong Medical 08 09
Corporate Culture Honors
Zhonghong Medical deeply engaged Zhonghong Medical Guilin HBM
A future-leading smart Zhonghong Medical
in the healthcare sector strive to
and a trustworthy centuryold enterprise
become a digital modern enterprise National Specialized and
benefiting all stakeholders and leading Top 50 Medical Device Companies by Revenue Innovative “Little Giant” Enterprise
the industry's future development.We aspire to become a healthy and China Association for Medical Devices Industry Ministry of Industry and
sustainable century-old enterprise that Information Technology of the
is trusted by customers employees Corporate People's Republic of China
partners shareholders and the society. vision
Guided by the corporate mission the First-class
Company builds a career platform to leadership Fulfill the High-Tech Enterprise Hebei Province Manufacturing Top 100 Enterprises in
fulfill employees' dreams of career Authentic Core dream of Single Champion Enterprise China’s Rubber Industry
responsibility values Office of the Leading Group development and personal growth. We Corporate growth for a for the Administration of the
provide the first-class products and Diligence first mission healthy life Hebei Provincial Department of China Rubber Industry Recognition of High-tech
services to help our customers create Mutual progress Industry and Information Technology Association
Enterprises
a healthy and quality life. We also
operate for good contributing to the
healthy and sustainable development Top 500 Most Valuable Guangxi 2025 Innovation 2025 CLS Zhiyuan Award - ESG
of a better society and creating values Chinese Brands ConsortiumPioneer Enterprise Award
for stakeholders constantly.The Evaluation Center of Brand Department of Science and
CLS
Union (Beijing) Consulting Co. Ltd. Technology of Guangxi Zhuang
Zhong
hong characte Autonomous Region rs
t
nce
p Inno
co
va Listed Company Golden t 2024 Shanghai Securities News
Guilin Innovation
Zhonghong's Bull Award - 2024 Golden
Guiding Golden Quality ESG Award
Consortium
Aspiration n G Information Disclosure Award
Principles Shanghai Securities News Guilin Science and Vision China Securities Journal
Utmost Sincerity Technology Bureau Mission of Pulin
and Excellence Values
Achieving Altruism 2024 Yongfu County Enterprise
Greatness and 2025 Listed Company ESG 2025 Listed Company Outstanding Win-Win Award for Outstanding
Far-reaching y t Value Communication Award Investor Relations Award c s Contribution to High-quality
Success onc Coept Industrial Development Shenzhen Value Online Shenzhen Value Online
Z Information Technology Co. Ltd. Information Technology Co. Ltd. ho os Yongfu County Committee of the nghong tabo Communist Party of China and
Yongfu County People's Government
GoldenBee Excellent Corporate
Sustainability Report 2025 2025 China Talent Management
Customer Responsibility Excellence Award
Information Disclosure Award
Beisen MedRena
GoldenBee ThinkTank
Talent Innovation Quality Cost
concept concept concept concept
Excellent Board of Directors Award at the 20th Golden Board Award Member of Shenzhen
Utilize employees ’ Innovate in Strict quality Lean for Listed Companies in China Association of Medical Devices
strengths integration control management
Hire excellent Transcend in Standards Driven by data Directors & Boards Magazine of Phoenix Publishing and Media Group Shenzhen Association of Medical
talents learning enforcement Devices
Talent
ghon
g's Asp
n irat
ho io
concept
uli
n Z
pt
n co
nce
io
ing P
rinciples
id ou f P
lit
Qua2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sustainability Management 10 11
Sustainability Management
Driven by its ESG strategy Zhonghong Medical continuously optimizes its sustainability management system. Under a three-tier
governance structure coordinated by the Board of Directors the Company integrates ESG objectives throughout its business Double Materiality Assessment
processes strengthens stakeholder engagement and accurately identifies stakeholder needs and expectations through regular
surveys and multi-party dialogues. This approach helps us improve our sustainability management mechanism and promote In 2025 building on its previous ESG impact materiality assessment Zhonghong Medical introduced a dedicated financial impact
cross-departmental collaboration to advance key ESG initiatives. Meanwhile the Company continues to strengthen its ESG analysis. In collaboration with financial experts external sustainability specialists and key internal and external stakeholders
policies and institutional framework forming a systematic operational approach that enables sustainability strategies from the Company conducted in-depth exchanges to systematically review stakeholder priorities and their financial transmission
planning to execution and translate sustainability principles into solid support for the Company’s long-term value creation. pathways to operating costs compliance risks supply chain resilience and brand value. For highly material topics the Company
established closed-loop management and transparent disclosure mechanisms promoting the deep integration of sustainable
development with the Company’s business strategy.Sustainability Management Structure
Based on top-level design Zhonghong Medical has established a three-tier governance structure — decision-making management We gather existing ESG practices
and execution — with the Board of Directors at the core. The Strategy and Sustainability Committee has been established challenges and plans from
under the Board along with the cross-departmental ESG Task Force to ensure that ESG topics receive high priority in various departments to create a
corporate decision-making. The Board oversees and makes overall decisions on sustainability-related matters; the Strategy and Dynamical preliminary ESG topic list.Sustainability Committee is responsible for setting ESG strategic directions and targets; and the cross-departmental ESG Task topic database We refine the list of ESG topics
Force advances and implements specific initiatives. Together they form a top-down highly coordinated ESG governance system updates by referring to domestic and
that provides a solid organizational foundation for the Company’s sustainable development. international standards best
industry practices and ESG
W e roll out stakeholder surveys disclosure guidelines.Deliberate and decide ESG work proposals. through targeted questionnaires W e add ESG topics that could
Decision- Research and judge major ESG risks and opportunities. and daily contacts.significantly impact the Company
The Board of
Formulate the working procedures of the Strategy and Sustainability W e gather from all parties the based on global ESG trends
making Directors Committee. concern risk perception and Stakeholder national policies and industry
Other responsibilities. improvement expectation for ESG surveys regulations.topics.We form a list of stakeholders needs
Study and formulate the Company’s sustainability strategy manage We evaluate the impact extent to provide a basis for subsequent
and oversee sustainability-related impacts risks and opportunities and likelihood and scope of ESG Strategy and assessment.propose recommendations. topics on the environment society
Management Sustainability
Committee R eview company realities and decide whether the sustainability report
and stakeholders based on the
disclosed by the Company complies with relevant regulations. research results.Other responsibilities. Double We quantify the transmission
materiality path and potential impact of ESG
assessment topics on the Company's operating
Define key objectives and action pathways for the Company’s income costs compliance risks
sustainability strategy to ensure that ESG work is aligned with business and brand value.operations. The ESG Task Force conducts W e prioritize ESG topics according
ESG Task
D evelop and refine ESG policies frameworks and processes. comprehensive and representative to the matrix model and screen
Force
C oordinate internal departments bring resources together and drive verification on high-priority topics. the highly material topics.sustainability project implementation. T he Strategy and Sustainability Topic
Execution Other responsibilities. Committee determines the final deliberation
topic list based on the Company's
and
Understand stakeholder expectations and needs timely. strategic objectives and resource disclosure
E xecute ESG tasks according to established deadlines and schedules. allocation.Company
Regularly report sustainability practices performance indicators and The Board of Directors finally
departments
typical cases. deliberates and approves the topic
O ther responsibilities. list.Zhonghong Medical sustainability management structure Zhonghong Medical double materiality assessment process2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sustainability Management 12 13
Stakeholders Expectations and appeals Ways of engagement
* Compliance with laws and * I mplementation of regulatory policy
Government
06 regulations guidelines
03
08 and * Response to national strategies * Participation in survey and visits24 regulators * Corporate governance * Daily supervision and reporting
02 * Anti-corruption and integrity * Information disclosure
01
17 22 1220 07 * Stable business performance * Shareholders' Meeting
* Sound corporate governance * Periodic reports and information
0914
Shareholders * Transparent information bulletins
disclosure * Investor surveys and communication
23 and investors * Enterprise risk management meetings
13 04 * P rotection of stakeholder rights * Roadshows and reverse roadshows
10 15 and interests * Online communication platforms
1121
18 * Responsible marketing system
* Responsible marketing documents
16
05 19 * P rotection of customer rights and * Customer complaint handling
Customers interests * Product presentation* Improvement of service quality * Customer discussion and return visits
* Unblocked service channels * O fficial website official WeChat
* R&D of innovative products account APP and other
communication platforms
Not significant Very significant
* Workers’ congress
Significance to the Company’s financial performance * Employee rights protection * Employee seminars
Zhonghong Medical double materiality matrix * Promotion of employee growth * Internal training system
Employees * Occupational health and safety * Performance and compensation
Environmental Product Social Governance * Compensation and benefits management system
responsibility responsibility responsibility responsibility * Inclusion and diversity * Labor union’s cultural and caring
activities
01 Climate change and 06 Product quality and safety 13 Equal employment 19 Corporate governance
carbon emissions 07 R&D technology and and protection of 20 Investor relations
02 Environmental innovation rights and interests management * Consultation on an equal footing * Exchange and visits
compliance 08 Building a responsible 14 Employee training and 21 Business compliance Suppliers and * Honesty and integrity * Seminars
management supply chain development 22 Business ethics and partners * Complementary advantages * Signing of agreements
03 Resource utilization 09 Healthcare accessibility 15 Occupational health anti-corruption * Mutual benefits * Industry research
04 Waste and pollutant 10 Responsible marketing and safety 23 Information security
discharge 11 Customer privacy 16 Employee care 24 Digital and intelligent
05 Green office protection 17 Industry development transition * * Implementation of energy saving and Energy saving and emission 12 High-quality customer 18 Support for community- emission reduction policies
reduction
service based charity
Environment * * Environmental data collection and Green manufacturing
* disclosureGreen operation
Stakeholder Engagement * * Digital energy management platformGreen supply chains * Non-profit environmental activities
Zhonghong Medical has established diverse and unblocked stakeholder engagement channels. Business departments take * Sudden disaster and accident * Emergency response training
the lead in conducting targeted dialogue with stakeholders based on their relevance to the medical device industry chain. The response * National thematic public welfare
Company has always been attentive to the concerns and expectations of key stakeholders including regulators suppliers Communities * Devotion to public welfare activities
employees and local communities. We fully integrate their feedback into our operation and decision-making sustainability * Response to social concerns * Charity fund
strategy planning the identification and response to risks and opportunities as well as the formulation of goals and indicators.Through collaboration and co-creation we strive to promote harmonious coexistence and shared growth with our stakeholders.During the reporting period the Company identified seven key stakeholder groups: government and regulators shareholders
and investors customers employees suppliers and partners environment and communities.Very significant
Significance to economic social and environmental impacts关于我们
2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report ASpbotulitg Zhht：onDgihgoitnagl FMuteudrieca Ilntelligent Healthcare 14 15
Spotlight： StrategyZhonghong Medical upholds the transition philosophy of “digitally empowered business and intelligence-drivenDigital Future Intelligent Healthcare development” and the principle of “customer at center data at core efficiency as goal”. We strive to digitalize our operations through process optimization technological innovation and data empowerment thus enhancing operational
efficiency upgrading management model and delivering greater business value.Risk Risk Likelihood of Impact Financial ResponseIn 2025 aligned with its overall development strategy Zhonghong Medical actively advanced the philosophy of “driving category description occurrence duration impact measuresbusiness innovation through digitalization and enhancing management efficiency through intelligent technologies”.The Company systematically promoted key initiatives for its digital and intelligent transformation driving the Regularly conduct
implementation of a number of key digital projects covering multiple dimensions such as intelligent manufacturing The rapidly iterating digital Increased initial technology
office coordination data governance and process optimization. These efforts delivered notable results in improving technologies requires management benchmarking and Technology
operational efficiency optimizing operating costs and enhancing management precision laying a solid digital and higher adaptability of Medium Medium expenses capability enhancement risk
intelligent foundation for ESG development. existing systems and affected initiatives and
application capability. profitability. dynamically optimize
system iteration paths.Governance Digital transformation Advance intelligent
involves cross-departmental process reconstruction
Zhonghong Medical has established the Digitalization Management Department as the core management body for collaboration and core in phases implement Increased
the Company’s digital and intelligent transformation. The department convenes a dedicated meeting each quarter Execution risk business process High Short transitional alignment operating costs.to review the progress of digital transformation initiatives risk assessment results and major actions and holds a restructuring may lead plans and promptly
monthly meeting to coordinate and resolve operational issues and track the progress of ongoing tasks. At the same to information gaps and coordinate to resolve
time the Company enhances employees literacy of digital and intelligent technologies through professional training coordination breakdowns. collaboration issues.and technical exchanges building a high-performing and specialized team to manage digital transformation initiatives.Opportunity Opportunity Likelihood of Impact Financial Response
category description occurrence duration impact measures
Formulate the macro-strategic direction key decisions and annual work plan The development of Promote digital
Digitalization concerning digital and intelligent transformation and regularly oversee and AI big data and other reconstruction of
Management evaluate the implementation of relevant work. Technological emerging technologies Decreased High Long business processes to
Department Act as an executer to lead the implementation of relevant management measures opportunity provides innovative operating costs. achieve end-to-end
and build and maintain internal digital and intelligent operation system. solutions for intelligent digital collaboration.digital transformation.Establish a digital
Digital and intelligent management closed-
transformation drives loop system and
Decreased
Each Management management upgrades use data to optimize
Work with the Digitalization Management Department to ensure effective High Long administrative
business opportunity enhancing overall resource allocation
implementation of relevant work. expenses.department operational efficiency and and strengthen cross-
core competitiveness. level management
collaboration.Digital and intelligent transformation framework关于我们
2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report ASpbotulitg Zhht：onDgihgoitnagl FMuteudrieca Ilntelligent Healthcare 16 17
Impact risk and opportunity management Building a digital energy management platform
Zhonghong Medical has established a risk management mechanism for digital and intelligent transformation featuring
“strategic guidance – dynamic assessment – targeted measures – closed-loop optimization”. We proactively identify
risks and opportunities related to digital and intelligent transformation. Through phased implementation integrated In 2025 Zhonghong Medical addressed high energy consumption in production by building a digital
resource allocation and performance evaluation we ensure risks are effectively controlled and opportunities are energy management platform that can collect monitor and analyze real-time data on electricity and
captured securing the solid delivery of transformation outcomes. gas usage. The platform also automatically detects abnormal energy consumption and issues alerts
helping production teams optimize energy usage. During the reporting period the Company significantly
reduced energy consumption per unit of product year-on-year achieving both cost reduction and green
development goals.Building a digital platform Digitalizing business processes
We have built a unified data hub that integrates We digitalize and optimize our core business
internal and external data. Our standardized processes and work to eliminate information Metrics and targets
data warehouse enables centralized data silos achieving full-process digitalization
management and sharing providing data across order management manufacturing In response to China’s intelligent manufacturing strategy Zhonghong Medical continues to increase investment in
support for business decision-making. logistics and customer service. digital transformation. The Company is building advanced digital factories and introducing intelligent production
equipment and management systems to automate production processes. Through these efforts we work to fully
leverage digital technologies to improve efficiency and precision reduce costs and risks and contribute to the broader
advancement of digitalization.Digitalizing manufacturing Promoting digital office
We promote in te l l igent upgrades in We leverage digital office tools to enable
manufacturing through an industrial internet mobile work for all employees and have built a
platform that realizes data collection collaborative platform that supports workflow
analysis and precise control of production approvals document sharing instant
equipment improves quality control and messaging and meeting management.reduces energy consumption.Corporate digital and intelligent transformation
Building a financial shared service center
In 2025 Zhonghong Medical established and launched a financial shared service center. By integrating
company-wide finance functions including accounting expense reimbursement and cash management
the center centralizes and analyzes financial data in real time standardizes and automates processes
and enables online submission intelligent review and automatic payment of expense claims boosting
accounting efficiency by 60% and significantly reducing human errors.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report A Green Defining Feature Worth Protection 18 19
A Green Defining
Feature Worth
Protection
Committed to green development Zhonghong Medical continuously
improves its environmental management system compliant
operations and risk prevention. The Company enhances resource
management efficiency through technological innovation and
process optimization achieving intensive and circular resource
utilization. We focus on key pollution control measures to strictly limit
emissions and upgrade end-to-end governance from source
reduction to process control contributing ecological restoration and
harmonious coexistence between human and nature.Material topics
Environmental compliance management
Climate change and carbon emissions
Resource utilization
Waste and pollutant emissions
Green office
Contributions to UN SDGs2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report A Green Defining Feature Worth Protection 20 21
Environmental Compliance
Management
Opportunity Opportunity Likelihood of Impact Financial
category description occurrence duration impact Response measures
Governance Market demand for Increased Increase investment in green manufacturing
Green biodegradable low- revenues build green factories and develop recyclable
manufacturing pollution medical High Long increased and biodegradable solutions for disposable
Zhonghong Medical has established and obtained ISO 14001 certification for its environmental management system. With sound opportunity protective products market protective products to reduce environmental
EHS management systems our subsidiaries have formed multi-tier oversight mechanisms that include routine supervision continues to grow. shares. costs per unit of output.environmental impact assessment and environmental monitoring. They have incorporated environmental management
indicators and targets into their management performance evaluations to comprehensively enhance environmental
management capabilities. In 2025 the Company reported no environmental administrative penalties pollution incidents or major
environmental accidents. Impact risk and opportunity management
Zhonghong Medical systematically reviews environmental risks in its operations assesses risk levels and implements targeted
As the primary person responsible for the Company’s environmental protection efforts mitigation measures. Through regular monitoring and dynamic control the Company continuously refines its response strategies
General Manager the General Manager is responsible for formulating and communicating environmental and has established a management framework incorporating pre-warning in-process response and post-optimization to
management policies. effectively prevent compliance risks and environmental incidents.Led by the Safety and Environmental Protection Department the team is responsible
Environmental for the inspection department coordination data analysis renovation and upgrading of
Leadership Team environmental protection facilities etc. to ensure the compliant disposal of the three We have established environmental factor identification procedures to comprehensively correctly
wastes and the discharge of pollutants. Environmental and effectively identify environmental factors throughout the Company's activities products and
services.Company departments are responsible for promoting and implementing specific factor
Company Departments identificationenvironmental management tasks. We carry out comprehensive environmental factor reviews and updates every year to ensure
effective identification.Environmental governance structure
Strategy Environmental W e have formulated environmental emergency plans for hazardous waste and other factors and incident regularly carry out emergency drills against environmental incidents such as pollutant leakage
prevention and hazardous waste fire every year to improve our response to environmental emergencies.Following the philosophy of “green development and compliance first” Zhonghong Medical has established an integrated
management system covering compliance management resource conservation and pollution prevention. Guided by
laws and regulations the Company continues to strengthen environmental governance through institutional frameworks
technological optimization and process control. We aim to promote energy conservation and recycling measures and implement
comprehensive monitoring and precise pollution control thus achieving coordinated economic and ecological benefits. Environmental
monitoring
and Emission abnormalities are pre-warned through internal real-time monitoring system.Risk
category Risk description
Likelihood of Impact Financial
occurrence duration impact Response measures inspection
The medical consumables industry Continuously upgrade waste gas and
Increased
faces stringent environmental wastewater treatment systems introduce Environmental risk control process
Pollutant operating
compliance requirements; delayed industry-leading environmental protection
control Medium Medium costs
upgrades in treatment processes treatment technologies and establish a
risk decreased
or inadequate controls may lead to real-time monitoring system for pollutant Metrics and targets
revenues.excessive emissions. emissions throughout production.Introduce bismuth-based catalysts and Environmental governance target Progress in 2025
The development of new technologies
soft-hard segment gradient design to
and products is time consuming; Increased Compliant exhaust gas emissions Fulfilled
Process develop low-consumption low-emission
pilot production may generate High Long operating
risk technologies and products that can
pollutants; process bottlenecks can costs. Compliant wastewater discharge Fulfilled
improve resource efficiency and reduce
lead to low resource utilization.pollutant emissions. Compliant waste disposal Fulfilled2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report A Green Defining Feature Worth Protection 22 23
Resource Conservation
Efficient resource utilization is Zhonghong Medical’s core driver for environmental protection. Through strategic planning and Our Scope 1 emissions primarily result from the combustion of fossil fuels including gasoline diesel natural gas and coke oven
technological innovation the Company has established a refined full-chain management system covering energy water and gas. Scope 2 emissions arise from indirect emissions associated with purchased electricity and steam.materials supporting low-carbon transition.In 2025
Energy management Total GHG emissions Scope 1 GHG emissions
Zhonghong Medical leverages technological innovation and refined management practices to optimize energy parameters and 851780.57tCO2e 3206.49tCO2e
production process adaptability. The Company actively promotes energy-saving technologies and eco-friendly equipment
strengthens employee awareness and advances initiatives across multiple dimensions—from technology application and GHG emissions intensity Scope 2 GHG emissions
equipment upgrades to personnel management—achieving both energy and emission reductions as well as cost optimization. 3.5892tCO2e/RMB 10000 848574.08tCO2e
Guilin HBM promotes energy conservation and carbon reduction
Water resource management
Guilin HBM has achieved energy conservation and carbon reduction by optimizing both production and public utilities. On
the production side automatic temperature control systems are installed to adjust the fan inlet temperature of ovens in real Zhonghong Medical strictly complies with laws and regulations such as China’s Water Law. Guided by the principles of science-
time precisely managing energy demand and reducing steam consumption. On the utilities side manual monitoring and based water management and water conservation first the Company advances water resource management by exploring
intervention are applied to central air-conditioning and chiller units dynamically adjusting return water temperatures and effective approaches and increasing investment in water resource protection. Watersaving and consumptionreduction
reducing unit operating frequency to prevent increased electricity consumption caused by weather fluctuations. requirements are fully integrated throughout its production and operational processes to build a waterefficient enterprise. The
Company’s primary water sources are municipal water supply and ground water and all water withdrawal and drainage activities
do not have any significant impact on water resources.Indicator Unit 2025 In 2025
Total energy consumption tce 257653.20 Total water consumption Domestic water consumption Industrial water consumption
Direct energy consumption tce 2217.06 2941536.94 tons 295803.64 tons 2645733.30 tons
Indirect energy consumption tce 255436.15
Gasoline liter 23514.98 Packaging material management
Diesel liter 61129.77
Natural gas m3 110630.45 Upholding the environmental sustainability philosophy Zhonghong Medical has implemented environmental requirements
throughout the entire process from material selection to packaging recycling. The Company prioritizes low-VOC an eco-friendly
Coke oven gas m3 3203744.00 raw and auxiliary material and strictly follows relevant standards to ensure quality. We implement the packaging recycling
Purchased electricity MWh 398951.91 mechanism by requiring suppliers to collect and reuse packaging boxes reducing waste generation. Meanwhile we strengthen
supplier environmental assessments enforce green procurement and offer employee training to improve resource efficiency
Steam ton 2138596.71 and fulfill our environmental responsibilities.Guilin HBM launches “Plastic and Carbon Reduction”
packaging upgrade project
In 2025 Guilin HBM launched the “Plastic and Carbon Reduction” packaging upgrade
project adopting an FSC-certified kraft paper card combined with a recyclable
Packaging material consumption PE window film in a non-laminated structure. Product information is printed with
13643.71 soy-based ink replacing traditional laminated film packaging to reduce heavy metal pollution. The new packaging has received positive customer feedback. tons2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report A Green Defining Feature Worth Protection 24 25
Waste and Pollution Control Green Offices
Zhonghong Medical has established such regulations as the Hazardous Waste Prevention Responsibility System and Wastewater To build green offices Zhonghong Medical promotes energy and carbon reduction practices including digital operations energy
Waste Gas and Noise Pollution Prevention and Control Procedures. These documents define the emission standards monitoring management green commuting and environmental education. The Company continuously optimizes office operations to reduce
mechanisms and treatment processes for pollutants including waste gas wastewater solid waste and noise. The Company resource consumption and carbon emissions fostering a low-carbon eco-friendly work environment.has built a closed-loop system of “monitoring and early warning targeted control strict management” supported by multi-
dimensional monitoring mechanisms for wastewater waste gas noise and waste. The systems enable real-time collection and
uploading of emission data with anomaly alerts while clearly defining concentration and total discharge limits to ensure real- Green office measures
time tracking and dynamic supervision of pollutant emissions.In 2025 Green office
Total wastewater Introducing paperless offices through information system.Industrial wastewater Domestic wastewater
2792250.90 Implementing double-sided printing to reduce the use of printing paper. m3 2519299.21m3 272951.69m3 P romoting video conferencing instead of face-to-face meetings to reduce carbon
emissions arising from business travel.Total solid waste
Non-hazardous waste Hazardous waste
2965.35 tons 2200.92 764.43 Green electricity tons tons
O ptimizing energy-consuming equipment and consumption management purchasing
high energy-efficient air conditioners and setting the cooling temperature in summer to
Pollution prevention and control measures no less than 26 ℃ .Renovating the lighting system installing energy-efficient bulbs and ensuring lights are
switched off after working hours to reduce office electricity consumption.Waste gas Wastewater Solid waste Noise Green commuting
Installing EV charging piles at manufacturing sites and parks to encourage the use of
For emissions from Upgrading production H azardous waste: Optimizing industrial new energy vehicles.coal-fired boilers process to reduce entrusting qualified layout and tightening Encourage employees to commute via public transport shared bicycles and other green
volatile organic hazardous waste professional agencies with noise protection modes of mobility to reduce carbon emissions.compounds and other emissions. the harmless disposal of measures.air pollutants applying Promoting wastewater hazardous waste strictly Tightening prevention
tailored combined treatment technology following compliant and control of vehicle
treatment processes and equipment to transfer procedures as noise and introducing Green culture
for efficient purification improve efficiency. well as establishing and low-noise engines
to achieve compliant S eparating storm maintaining detailed and sound insulation Carrying out regular publicity on ecological conservation energy saving and carbon
emissions. and sanitary sewer management records. equipment. reduction to raise green development awareness.systems and installing Non-hazardous waste:
Organizing afforestation and waste sorting campaign to practice the green philosophy.sewer pipelines and prioritizing classified
rainwater ditches. recycling entrusting
qualified agencies with
the recycling of such
Extended reading recyclables as corrugated
paper and packaging lining
For more pollutant discharge information please paper and entrusting
refer to Zhonghong Medical Annual Report 2025. environmental sanitation
departments to handle
other non-hazardous waste.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 26 27
Quality at Our Core
and Service with
Craftsmanship
Zhonghong Medical strictly controls the entire product
qua l i t y p rocess and proact i ve ly es tab l i shes a
standardized and responsible supply chain system. We
improve an efficient and convenient customer service
response mechanism to enhance customer experience
and satisfaction while systematically mitigating potential
risks in quality control supply chain operations and
customer service. With customer demands as the core
driving force we upgrade our product innovation and
services to strengthen our brand resilience.Material topics
R&D technology and innovation
Product quality and safety
Building a responsible supply chain
High-quality customer service
Responsible marketing
Customer privacy protection
Contributions to UN SDGs2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 28 29
Innovation-driven Development
Governance Opportunity category Opportunity description Likelihood Impact Financial period impact Response measure
Increased efficiency in the We have established an
Zhonghong Medical regards its research institutes as the core departments for innovation and R&D management namely the
conversion of R&D achievements evaluation mechanism for
Tangshan Research Institute Shanghai Research Institute Yichun Research Institute Shenzhen Research Institute Guilin Research
with patented technologies and the conversion of R&D
Institute and Hainan Subsidiary which form its R&D system. The research institutes oversee the entire R&D process including Technology Increased
core processes being industrialized Medium Long-term achievements to track the
organizing the formulation of annual R&D plans promoting project initiation conducting R&D and facilitating project evaluation opportunity revenue.will form a unique technological results and continuously
and patent applications. In terms of personnel the Company recruits specialized talent with master's and doctoral degrees builds
advantage and continuously optimize the technology
innovation platforms and refines promotion mechanisms forming a multi-departmental collaborative R&D team that covers
strengthen core competitiveness. implementation process.production technology sales and management. The responsibilities of R&D personnel are clearly defined. Additionally the Company
has established R&D management regulations such as the R&D Management Measures Reward Measures for R&D Achievements
and the New Product Development Management Measures ensuring the professional capabilities and motivation of the R&D team.Ultimately they will support the Company's technological development and strategic layout in the medical device field.Risk opportunity and impact management
Strategy Zhonghong Medical consistently integrates the management of R&D risks and opportunities into the entire innovation process.Grounded in strategic development the Company keeps a close eye on industry trends and market demand enhancing overall
Guided by the innovation concept of "innovate in integration and transcend in learning" Zhonghong Medical focuses on planning and systematic analysis. We work to prevent and resolve various potential risks while accurately identifying and seizing
formula optimization process upgrades and functional expansion to meet market demands and be at the industrial frontier. By development opportunities ensuring the steady progress of R&D innovation activities.integrating internal R&D platforms' talent equipment and data resources the Company connects the chain of R&D pilot testing
and industrialization to quickly transform technological achievements. With continuous learning as the core driving force we
strengthen frontier technology research and reserves through industry benchmarking technical exchanges and employee Identification Evaluation
training striving to expand product lines and enhance the core competitiveness of our products. Furthermore to enable open
innovation we improve internal multi-departmental collaborative R&D mechanisms and full-process management systems W e analyze technological bottlenecks in W e quantify and analyze the risks and
stimulating the vitality of all employees through tiered incentive policies. Externally Zhonghong Medical actively collaborates R&D and assess the reserve of cutting- opportunities related to R&D innovation.with universities technical teams and other external innovation resources. Joint R&D and technological cooperation is launched edge technologies. W e systematically summarize key
to overcome industry technical bottlenecks. We conduct research on market demand information about risks and opportunities
competitor dynamics and policy trends and identify priority areas.Risk Risk description Likelihood Impact Financial category period impact Response measures
and collect customer improvement
requests.Weak self-innovation capability
We regularly conduct business We analyze the need for production
insufficient forward-looking
training cross-enterprise process optimization and potential
research on cutting-edge industry Sluggish
Technology technology exchanges and industry cost-reduction opportunities. R&D risk
technologies notable gaps in core Medium Long-term revenue
risk benchmarking to systematically We assess risks related to R&D
technology reserves lead to the growth. management
improve the technology level of the input-output and compliance costs.difficulty in quickly responding to
R&D team. process
technological iteration demands.Adequate insight into market demand We have established a coordination Review Response
and lack of predictive ability regarding mechanism between the sales
market trends and potential customer Medium- Revenue marketing and R&D departments to
Market risk Medium
needs result in a disconnect between term decline. share market demand information W e conduct a comprehensive review We develop specialized plans to
product development and actual in real time and accurately capture and evaluation of risk and opportunity address risks including technology
market demand. potential customer needs. response effectiveness resource enhancement demand insights
investment and any issues encountered. and compliance control and drive
We strictly enforce the R&D
Gaps in full-process compliance We summarize lessons learned and opportunities such as pilot testing of
Management Measures and
management in R&D including optimize the R&D process reward new products process optimization
Increased standardize the entire process from
Management nonstandard project initiation Short- mechanisms and risk control systems. project applications and collaborative
Low compliance project initiation implementation
risk approvals delayed archiving of term We update the risk and opportunity list R&D efforts.costs. and completion to results
R&D documentation and weak and incorporate it into the next year’s W e create project execution plans clearly
transformation ensuring each step
budget control. R&D plan. defining roles and timelines.is properly managed.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 30 31
Promoting Reliable Products
Strengthening
technological
product R&D
innovation
W e have conducted research on latex applications We have launched low-weight high-end nitrile gloves Governance
vu lcan izat ion temperatures and other process to fill gaps in niche markets and meet diversified health
technologies. Through refined control of the vulcanization protection needs. Zhonghong Medical has established a product quality governance framework creating a quality management network that
process we have reduced production energy consumption involves all employees from senior leadership to frontline staff. In accordance with domestic and international medical device
and quality fluctuations while improving the mechanical laws regulations and standards the Company has developed a product quality management system that includes quality manual
properties and durability of products. procedure documents management system and operation documents. In 2025 the Company proactively accepted external
We have established internal safety testing methods for supervision by engaging third-party agencies to conduct annual external audits. Zhonghong Medical has successfully passed
food-contact nitrile gloves to ensure product compliance and several international certifications including the EU CE marking US FDA certification ISO 9001 quality management systems
consumer safety. ISO 13485 medical devices quality management systems Medical Device Single Audit Program (MDSAP) and BRC certifications
among others. We continuously improve our product quality management system(QMS) to ensure its suitability adequacy and
effectiveness. Zhonghong Medical has formed a cross-departmental product quality management team composed of members
Guilin HBM's dual projects selected for innovation consortium with expertise in various fields. This team includes department heads technicians quality inspectors internal auditors sales staff warehouse managers after-sales service personnel procurement staff and production operators. They oversee product quality
from different perspectives enabling comprehensive and refined management throughout the entire product life cycle.In 2025 Guilin HBM continued to prioritize "enterprise-driven market-oriented and deeply integrated industry-
university-research collaboration" as the core approach to technological innovation. It actively participated in
technological breakthroughs and resource integration. Two of Guilin HBM's projects "Guangxi High-Performance
Polymer and Biodegradable Materials Innovation Consortium" and "Guilin High-Performance Latex Application
Technology Innovation Consortium" were successfully selected for the 2025 Innovation Consortium list of the Guangxi
Zhuang autonomous region and the second batch of Guilin's innovation consortium respectively. These projects aim
to achieve more breakthroughs from "0" to "1" in key fields.Guilin HBM's third-generation PI material introduced
Common medical gloves and condom materials on the market are primarily made from natural rubber latex which
generally presents issues such as poor user experience and protein allergy risks. Guilin HBM has independently ISO 9001 quality ISO 13485 medical device MDSAP certification British Retail Consortium
developed its third-generation polyisoprene (PI) material which offers multiple advantages including superior management systems quality management system (BRC) certification
softness better skin contact no allergy risks and high elasticity. This innovation provides consumers with an certificate certificate
unprecedented level of comfort and safety.As the highest authority in the Company's QMS the general manager is responsible
General
Metrics and targets for defining the roles and responsibilities related to product quality management and manager ensuring the necessary independence and authority for accomplishing these tasks.Zhonghong Medical focuses on breakthroughs in core technologies tackling critical challenges in the health protection field. By Commissioned by the general manager the management representative is fully
benchmarking international advanced standards the Company aims to create a product matrix that combines innovation and responsible for the daily operation maintenance and oversight of the Company's QMS.competitiveness. With continuous investment in R&D we strive to empower our global market expansion and contribute to the Management This role coordinates quality-related work across departments ensuring the system's
innovative upgrading of the healthcare industry. representative conformity and effectiveness while promoting the implementation of corrective and
preventive actions.In 2025
R&D Patents obtained Invention Utility model Design Company Each department is responsible for advancing and executing specific product quality
R&D investment personnel in total including patents patents patents departments management tasks.RMB113.1865million 625 240 64 128 48 Product quality governance framework2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 32 33
Strategy We identify potential risks opportunities and stakeholder demands across various stages including
design procurement production inspection and delivery and develop response strategies.Zhonghong Medical's product quality management strategy focuses on the core principles of "system optimization risk Identification We map the sequence and interconnections of QMS processes and identify the risk transmission
prevention efficiency improvement and sustainable improvement." The Company aims to ensure product quality stability and analysis paths between processes.compliance and efficiency while supporting business expansion through digital transformation supply chain enhancement and Based on stakeholder demands we define the responsible parties and control authorities for risk
capacity building for all employees. management within the product quality management process.Risk categry Risk despcription Likelihood Impact Financial
W e analyze identified risks and opportunities and assess the likelihood impact period severity
period Impact Response measures and risk level of potential risks.Increased We have built a company- Evaluation F or each risk level we predefine corresponding control measures clarify operational guidelines
Misinterpretation or inadequate
compliance wide quality awareness system and methods and monitoring and measurement requirements and create product quality risk control
implementation of national
costs strengthened employee prevention documentation.medical device laws and
Policy risk Low Long-term revenue understanding of ISO standards We allocate the necessary resources and information in advance for effective product quality risk
regulations leads to product
decline and PPE EN455 and other regulations management to ensure that control measures can be implemented.recalls public penalties or
reduced and enhanced overall quality
production stoppages.market share. awareness. W e implement product quality management processes in accordance with the requirements
We have established an efficient outlined in the product quality risk control documentation to ensure compliance with risk
Substandard product quality Revenue customer complaint response Control prevention protocols in operations like production and inspection.leads to decreased public and decline and mechanism improved processing and W e conduct daily monitoring of quality risk points for key products collect process data in real-
Trust risk consumer trust in the Company Medium Long-term decreased efficiency and strengthened the response time and promptly identify abnormal risk signals.and its products damaging market use of digital tools shifting from When product quality risks trigger an early warning we initiate the emergency response
brand reputation. value. traditional responses to data- mechanism and take immediate actions to contain the risk's spread.driven preventive management.Product quality risk management process
Incomplete identification of Increased
We prioritize the development and
stakeholder demands leads to operating
Management Medium- maintenance of a multi-standard
blind spots in product quality Medium costs and
risk term QMS and dynamically adjust it Quality inspection Management capability Market recognition Assessment mechanism
control and failure to meet revenue
based on stakeholder feedback. process optimization enhancement improvement guarantee
external quality requirements. decline.We have increased the We have conducted 12 quality- We have completed 38 We regularly inspect factory
incoming inspection project focused training sessions outsourced tests and obtained production quality control
Opportunity
catogory Opportunity description Likelihood
Impact Financial of raw material and auxiliary covering nearly 900 people. PPE extension certificates and equ ipment s ta tus
period impact Response measures materials and introduced Training topics include ISO from 10 customers to ensure incorporating the results into
We eliminate non-compliant related equipment. We also standards PPE EN455 and product quality complies with performance evaluations
suppliers improve the Lower updated Standard Operating other regulations with a focus standards. to ensure stable factory
We use a supplier auditing system
Supply chain quality and safety of the operating Procedures (SOPs) for key on reinforcing SOP training for operations.Medium- to identify and reduce supply
optimization supply chain enhance High costs and processes such as mixing production control personnel
term chain quality risks and eliminate
opportunity product quality stability and increased and dipping and refined and quality risk assessment
non-compliant suppliers.strengthen the Company's core revenue. parameter standards. methods for management.competitiveness.We strengthen quality Increased We increase investment in quality
Brand assurance capabilities increase revenue technologies and upgrade quality Metrics and targets
High Long-term
opportunity public and consumer trust and and higher testing equipment and control
loyalty in the products. market value. systems. In 2025 Product quality management
indicator 2025 target
Progress in
2025 Status
100 Nitrile product return rate Below 0.2% 0% Achieved% of the
Risk opportunity and impact management Quality training coverage rate Above 95% 100% Achievedbusiness scope covered by
the QMS certification for the Order delivery timeliness rate Above 90% 95.76% Achieved
Zhonghong Medical has established product quality risk control systems including the Risk Control Procedure and Risk and sixth consecutive year. Product customer satisfaction rate Above 95% 99.91% Achieved
Opportunity Response Control Procedure to create a closed-loop management system that covers risk identification early Procurement product pass rate Above 98% 100% Achieved
warning response and emergency handling. This system proactively prevents quality risks through a systematic mechanism No product withdrawals
ensuring the safety and reliability of products throughout their entire lifecycle. or recalls occurred. External audit pass rate Above 98% 100% Achieved2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 34 35
Sustainable Supply Chain
Zhonghong Medical continues to improve its supply chain management system proactively identifying potential risks and In 2025 Zhonghong Medical integrates environmental and social considerations deeply into the
growth opportunities. We build a resilient supply chain through diversification and rapid response systems capture new growth supplier admission process. The Company rigorously reviews suppliers for environmental
from digitalization and sustainability and unite our partners around a shared ESG vision. Potential suppliers disqualified compliance and labor rights protection prioritizing partners with ISO 14001 certification. During
due to social responsibility the cooperation process the Company strengthens dynamic supervision of environmental
non-compliance and social aspects through regular assessments on-site audits and special audits. Suppliers
Supplier management 0 are required to sign the Suppliers Social Responsibility Audit Checklist and the Supplier Commitment to Compliance and Continuous Improvement of Social Responsibility and to
include environmental and social responsibility clauses in contracts to foster a responsible
According to the Supplier Management Control Procedure Zhonghong Medical creates a comprehensive management supply chain.mechanism that covers supplier entry evaluation auditing incentives and exit. A cross-departmental collaborative control Suppliers whose cooperation
model is in place to define responsibilities and boundaries at each stage. With dedicated teams and continuous training the was terminated due to
Company has secured a solid foundation for supplier management. social responsibility non-
compliance
In 2025
Suppliers are initially screened based on technical and quality 0
Suppliers in total requirements. Qualification documents are collected and verified
Supplier selection
934 to ensure compliance.and qualification Supplier types such as manufacturers agents and service providers review
are differentiated. Review standards are matched to the risk level of
materials with on-site inspections conducted for high-risk categories.Local suppiers
636 Suppliers are classified into A/B/C tiers based on how their materials affect product quality. Management qualification reviews
Supplier
sample testing and approval processes are all tiered accordingly.classification
Local procurement Once approved suppliers are included to our qualified supplier list approval and On-site supplier audits
and corresponding cooperation agreements are signed. Nationally
932.76 admission recognized professional agencies are directly included in the scope RMB million of collaboration exempt from additional evaluation. Supplier social responsibility requirements
W e continuously monitor supply quality on-time delivery rates
and service responsiveness and collect quality feedback and
Quality and
information related to the handling of unqualified products.performance
F or suppliers with quality issues we issue corrective action notices
tracking during
track the effectiveness and initiate the exit process if corrective
cooperation
actions are ineffective. We also sign quality agreements according Employee rights Environmental responsibility Social value
to supplier tier to clarify responsibilities.C ompliance with national and Compliance with national and P articipation in social
At the end of each year we organize a multi-department evaluation local labor laws international local environmental protection responsibility projects and
and score suppliers based on qualification validity quality service and labor standards and industry laws and regulations. charitable activitiesto give back
Annual supplier delivery capabilities. regulations. Improvement in resource utilization to society.re-evaluation Based on the scores we reclassify suppliers. Those who do not meet P rovision of fair wages efficiency and implementation S trengthening of CSR
standards are eliminated while those requiring improvements are given compliant working hours and of energy-saving and emission- management across the
deadlines for corrective actions which helps optimize the supplier pool. safe working conditions. reduction measures. supply chain conducting
P rohibition of child labor forced S tandardization of production environmental and social
We create a file for each qualified supplier archiving qualification labor and other violations and waste disposal processes responsibility assessments
documents agreements evaluation reports and other materials to adherence to the principle of and establishment of a waste of lower-tier suppliers and Supplier control
ensure traceability. promoting collaborative
mechanism fair employment. recycling and reuse mechanism.We establish a backup supplier system assigning backup suppliers for compliance throughout the
C ontrol of carbon emissions
critical materials to mitigate the risk of supply chain disruptions. supply chain.and adherence to low-carbon
production.Supplier management process2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 36 37
In 2025 Zhonghong Medical drives its transformation through digitalization. We have established a
transparent procurement platform to achieve full-process visibility and control supported by Premium Service
Proportion of local suppliers regular inspections and random checks. Together they reinforce the integrity safeguards. The
68 Company actively practices green procurement by selecting environmentally friendly materials to reduce environmental impact. The Company also implements a localized procurement % Zhonghong Medical is committed to putting the customer at the center integrating premium service into every stage of its
strategy to optimize the supply chain layout and support local economic development building operations. Through a full-cycle service system multi-channel communication mechanisms comprehensive protection of
a compliant transparent green and resilient sustainable supply chain ecosystem. customer rights and responsible marketing practices the Company continuously optimizes its service capabilities and customer
Proportion of localized experience. We work to build customer trust through professional efficient and compliant services.procurement Transparent procurement system
79 W e adhere to the principles of "openness and transparency standardization collective % Higher service quality and efficiency
decision making smooth processes supervisory and information sharing" to establish
a transparent procurement system.Zhonghong Medical works across multiple areas including product line optimization technological innovation stringent product
We have developed a transparent procurement platform that integrates information quality control supply chain and logistics management upgrades service process improvements and stronger after-sales support to
release process control contract signing and payment settlement. We ensure data consistently elevate the quality of customer service. This ongoing effort has earned the trust and support of its customers.security through separation of duties tiered management and dual confidentiality
mechanisms enabling fully electronic and transparent procurement operations. Improving the customer service process
We clearly outline the transparent procurement process in which the requesting department
submits procurement applications with specific requirements. We evaluate potential suppliers In 2025 Refined pre-sales service Efficient in-sales service Comprehensive after-sales service
through multiple channels. After negotiations and contract signing we issue orders track
execution and make payments upon receipt of satisfactory goods as per the contract terms. Issued and collected We build professional service We have established a fast- We have developed a robust
customer satisfaction teams to offer comprehensive response order processing after-sales service system that
Green procurement system questionnaires product consultations and system to ensure the timely includes product operation training
20 tailored hospital admission and accurate reception review clinical technical support prompt We have established a green procurement policy that defines environmental plans. We also accurately align and handling of orders. We response to customer complaints
protection principles procurement standards and supplier selection processes to with customer needs assist also provide efficient delivery and closed-loop issue resolution
ensure the materials and services we purchase meet environmental requirements. them in selecting the most services and real-time order which repeats purchases and
Customer satisfaction rate suitable products and provide tracking allowing customers fosters positive word-of-mouth
We prioritize suppliers certified to ISO 14001 environmental management systems.
100 full-cycle support throughout to clearly monitor product laying the foundation for long-term % the admission process. delivery progress. partnerships.Localized procurement
We actively increase the proportion of locally sourced raw materials and components Zhonghong Medical is customer-demand driven. We have built a multi-dimensional feedback
by prioritizing products and services from the local market thereby supporting local system covering the full lifecycle of our products and services enabling us to capture
economic development. customer concerns particularly related to health and safety in a timely and thorough manner.W e sign long-term cooperation agreements with high-performing local suppliers to
ensure the stability and reliability of our supply chain. Direct communication channels Exclusive service channels
During regular customer visits and business We provide 24/7 feedback access through
Responsible procurement engagements we proactively communicate online channels including a customer service with customers about product usage hotline official WeChat account and dedicated
experiences existing issues and suggestions service email. We also assign personnel to
Zhonghong Medical is committed to sustainable procurement. Through open communication for improvement. We document handle the screening categorization and
targeted training and end-to-end collaboration we empower our suppliers and drive these interactions in a Customer recording of customer inquiries.sustainability across the supply chain building a responsible network based on mutual trust Communication Record Form and
and shared success. promptly relay the feedback to
the relevant departments.Supplier communication Supplier training
Collaborative communication Industry communication channels
We strengthen communication and We actively organize supplier training
channels We actively participate in industry
collaboration with suppliers through activities that cover various aspects
We have established regular exhibitions academic conferences
multiple channels including phone calls including quality management supply
communication mechanisms with distributors and other events. We also engage with
text messages emails regular face- chain management and technological
and agents. We hold monthly partner meetings healthcare professionals industry experts
to-face meetings industry exhibitions innovation to enhance suppliers'
to gather consolidated feedback and market and peer companies to collect potential
and forums. These platforms allow both overall competitiveness.demands from end customers compiling the issues and areas for improvement identified
parties to share experiences discuss
insights into a feedback summary report. during the product usage process.issues and jointly develop solutions.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Quality at Our Core and Service with Craftsmanship 38 39
Protection of customer rights
Zhonghong Medical places a high priority on safeguarding customer privacy and has established a comprehensive management
system covering the entire lifecycle of customer information. The Company has implemented a "centralized management In 2025 Zhonghong Medical has also established a comprehensive after-sales service management
clearly defined responsibilities and coordinated collaboration" approach and set up a dedicated privacy protection task force led system including the Customer Feedback Control Procedure and Customer Complaint Control
Customer complaints
by department heads clarifying the roles and responsibilities of market sales after-sales IT and other relevant departments. To Procedure which clearly define the handling process for customer complaints and emphasize
ensure that all employees are well-versed in privacy protection requirements the Company regularly conducts policy briefings proactive problem resolution. A dedicated customer complaint team has been set up with
and specialized training sessions. A secure and reliable customer information management system has been put in place 306 multiple channels for customers to reach out including a hotline and email. For technical
featuring encrypted storage tiered access control and strict authorization protocols to prevent unauthorized access. Regular issues encountered during product use the customer service team guarantees a solution
internal audits and risk assessments are conducted to identify and mitigate potential vulnerabilities ensuring that privacy Customer complaint within 24 hours and more complex issues will have technical staff dispatched on-site within
protection measures are effectively implemented. During the reporting period the Company did not experience any incidents of resolution rate 48 hours ensuring timely and effective responses to customer needs.customer privacy leakage. 100 Zhonghong Medical upholds a philosophy of responsible marketing. From reviewing % promotional materials and standardizing product labeling to enhancing service capabilities the
Company takes a multi-faceted approach to ensure marketing integrity. Through institutional
Enhancing customer privacy protection controls professional training and end-to-end process management we ensure authentic
communications standardized product information delivery and fulfillment of our corporate
social responsibility in marketing.Standardized Following the principles of lawfulness legitimacy and necessity we clearly inform customers of Practicing responsible marketing
information the purpose scope and use of the information being collected and obtain their consent before
collection collection. No information unrelated to business operations is collected. Ensuring authenticity of promotions
W e have implemented a rigorous information review process that all product
materials used for external communications must be approved by the relevant
departments.Tighter We employ advanced encryption technologies to store customer information and build a robust
storage security infrastructure. Firewalls intrusion detection systems and other protective measures are in We strictly follow the principles of "review before release" and "case-by-case
security place with regular data backups and security checks to ensure the safety of stored information. approval" classifying content according to its intended audience to ensure all
promotional materials are accurate and truthful preventing the dissemination of
false or exaggerated information.Avoiding consumer misguidance
Strict We have implemented a tiered authorization system granting information access based on job
access responsibilities. Employees can only access customer information relevant to their work and all We adhere to strict brand standards in product marketing ensuring proper use
control access is logged to facilitate traceability and accountability. of product information and identifiers—from brand names and trademarks to
slogans and packaging. This guarantees consistent brand representation across
all channels and regions avoiding consumer confusion caused by inconsistent or
incorrect branding.Transmission When sharing necessary information with partners privacy protection agreements are signed
and sharing to define the scope of use and confidentiality responsibilities. Data transmission is encrypted to
management minimize the risk of information leakage.Information Customer information that is no longer required is securely destroyed following established
destruction procedures. Paper records are shredded and electronic files are permanently deleted ensuring a
procedures complete information security lifecycle.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report People-Centered Approach for Unity and Strength 40 41
People-Centered
Approach for Unity
and Strength
Zhonghong Medical values the contributions and aspirations of every
employee. We drive corporate growth through talent and innovation
while supporting employee development with structured systems.Through a comprehensive ecosystem for employee growth we
strive to create a fair inclusive and human-rights-respecting
workplace safeguard occupational health safety and well-being
and work with our employees to strengthen the foundation for
sustainable development.Material topics
Equal employment and protection of rights and interests
Employee training and development
Occupational health and safety
Employee care
Contributions to UN SDGs2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report People-Centered Approach for Unity and Strength 42 43
Employee Rights Protection Internship We select outstanding students through summer internships and university-enterprise
program collaboration programs with high-performing interns given priority for full-time job opportunities.Zhonghong Medical is committed to fostering harmonious stable and healthy labor relations. Focusing on core areas such as
human rights protection compensation and benefits transparent communication and employee care we strive to safeguard
the legitimate rights of every employee. By fostering a fair open and inclusive corporate culture we aim to fully unleash the
potential and value of our workforce. By participating in large-scale job fairs in universities and hosting on-campus recruitment Campus
sessions we strengthen university partnerships attract new graduates and build a pool of core
recruitment
talent for long-term development.Compliance in employment
In 2025 The Company strictly adheres to China’s Labor Law Labor Contract Law Regulations on the We publish recruitment information including job postings responsibilities and qualifications
Prohibition of Child Labor and other applicable local laws and regulations. We also align with on the "join us" section of our Company website official WeChat Weibo and Douyin accounts to
Total employees the principles and spirit of international conventions such as the International Bill of Human ensure transparency and standardization in the hiring process.
3884 Rights the Universal Declaration of Human Rights and the Convention on the Rights of
External We also deepen cooperation with leading job portals and medical industry-specific platforms to
Persons with Disabilities . Guided by these standards we have established and implemented recruitment attract highly suitable candidates.policies such as the Employee Recruitment Control Procedure and the Employee Handbook B y aligning with national employment support policies we expand available positions and provide
practicing recruitment that is fair transparent and open. Our expanded recruitment channel employment services with a focus on integrating rural labor and promoting job opportunities for
Employees from ethnic helps attract diverse talent and build a robust talent pool. key groups.minorities
208 We strictly prohibit the employment of child labor. The rule "no recruitment of individuals under 18 years old" is explicitly stated in our Human Resources Management Measures. During the recruitment
process candidate identity and age are thoroughly verified and all hiring records and verification Internal We select and transfer technical and managerial professionals internally and encourage employee
materials are carefully maintained. Through this full-process control system we effectively mitigate recruitment referrals to improve recruitment efficiency.Disabled employees labor-related risks. During the reporting period no incidents of child labor occurred.
44 Employee number by gender age and region
Total employee turnover rate Labor rules
29.05 1378% Number of male employees We have formulated the Human Resource Management Measures and the Control Procedure of Prohibiting Forced Labor to
ensure that all employment processes including recruitment hiring compensation promotion and training are conducted
Number of female employees fairly and responsibly. Any form of discrimination based on gender age ethnicity region marital status or religious belief is
2506 firmly opposed. Upholding the principle of equal pay for equal work we prohibit forced labor and strictly prevent harassment
or abuse providing all employees with equal opportunities for employment and development. In parallel we actively promote
localization of overseas employees strictly following local laws and regulations in compliance and HR management. In countries
such as Thailand Mexico and Malaysia all new hires are local nationals ensuring protection of their labor rights and fostering
366 a diverse inclusive and equitable workplace. During the reporting period no incidents of forced labor discrimination or 389 Employees under 30 years old harassment occurred and there were no significant labor disputes or human rights complaints.
Employees aged 30-50
3129 Employees over 50 years old
In 2025
19 Passed the BSCI
factory audit
Number of domestic employees
Number of overseas employees
3865 Obtained the WRAP
certification for social WRAP
Certificate
responsibility2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report People-Centered Approach for Unity and Strength 44 45
Compensation and benefits Employee Growth
Zhonghong Medical provides competitive salaries and growth opportunities. Policies such as the Employee Evaluation Management
Measures and Management Measures for Compensation Assessment of Middle-level Managers clearly define the composition and
Zhonghong Medical upholds talent as the key driver of development and
standards for basic and performance-based wages. Regular evaluations of job levels ensure that employee compensation is closely In 2025
continuously refines a full-cycle talent management system encompassing
aligned with role competencies and performance. Additionally we have established an efficient and scientific performance appraisal
selection utilization development and retention. Policies such as the Employee Zhonghong Medical was awarded the
system coupled with mechanisms for motivation accountability and communication effectively attracting and retaining top talent.Evaluation Management Measures Career Development Management Rules
Employee well-being is one of our priorities: working hours are reasonably scheduled wages are paid fully and on time and social 2025 China Talent
Training Management Measures and Measures for the Comprehensive Assessment
insurance including pension medical work injury maternity unemployment as well as housing provident fund are fully contributed.and Management of Employees During Probation Period guide this process. With a Management Excellence
Employees are also guaranteed statutory leave entitlements such as sick leave personal leave marriage leave maternity/paternity
robust training system fair incentive mechanisms and clear promotion pathways
leave breastfeeding leave and childcare leave. Award.we foster the continuous growth of both employees and the Company.Democratic management
Employee training
Zhonghong Medical respects employees’ rights to freedom of association and collective bargaining and has established the
Democratic Management System Incentive-Suggestion System and other related systems. The Company promotes democratic Zhonghong Medical has established the Training Management Measures and developed a dual-track training system combining
management underpinned by the Workers' Congress to engage employees in democratic management and supervision. We position-specific professional training and personal capability development. Through programs such as new employee
have set up a labor dispute arbitration and mediation committee with mediation and supervision offices to collect report and onboarding professional skills enhancement and management training as well as targeted digital managerial and business
address issues on human rights performance and career advancement. A labor union has been formed and reached formal support courses we equip employees with precise skills to grow. Training covers all levels and categories including strategic
agreements with the Company on working conditions compensation and benefits and occupational health and safety with a investment R&D marketing HR and finance ensuring core business units are fully supported. Leveraging the "Zhonghong
collective contract signed with all employees. In 2025 two employee grievance incidents were resolved. Academy" platform we offer a blend of online and offline courses across all business lines and job levels. Training includes
leadership development professional skills and general knowledge competencies providing employees with comprehensive
learning opportunities.Employee care
In 2025
Zhonghong Medical is committed to creating a warm and fulfilling workplace. Our "Staff Home" offers mental health counseling and
organizes a variety of activities such as parent-child sports events and National Day running competitions to help employees maintain Total training investment
a healthy work-life balance. Through the Presidential Fund we provide support to employees in need and the "Care Room" offers
female employees a space to meet special or temporary needs continuously enhancing overall employee satisfaction.RMB229800
Training sessions
432
"Gathering Talent at Zhonghong Leading the Future" 2025 new employee orientation camp
Number of employee training
2321
Total hours of employee training
17532.40 hours
Training coverage
59.76%
"Visiting Zhonghong Co-Creating the Future" university-enterprise cooperation program
Employee activities such as Chinese New Year fairs holiday celebrations and National Day running events — North China University of Science and Technology field research2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report People-Centered Approach for Unity and Strength 46 47
Promotion pathways
Zhonghong Medical has implemented the Career Development Management Rules establishing a dual-track development model for
management and professional paths. The policy clearly defines the criteria and qualifications for both routine promotions and exceptional
advancement providing transparency and motivating employees to enhance their skills. This ensures all employees have a clear roadmap
for career progression and encourages self-driven growth. Additionally we have formulated a series of rigorous selection systems including
the Job Descriptions for Zhonghong Medical Subsidiaries and Departments the Frontline Official Selection Methods and the Management
on Selection and Appointment for Middle-Level Management Posts to explore train and appoint talent. These systems enable employees to
continuously enhance their professional skills technical expertise and management capabilities.Management channel Professional channel
Grade
Management ladder Operations ladder Technical ladder
Level Rank Level Rank Rank ISO 45001 occupational health Signing of annual EHS responsibility agreements by safety officers and subsidiaries
and safety systems certification
11 General manager (Level 1) Principal (project) director Senior engineer
10 General manager (Level 2) Senior (project) director Engineer II
Middle
9 Executive vice president Director (Project) director A
management StrategyFirst level
8 Vice president (Project) deputy director B
engineer
7 Assistant general manager (Project) assistant director C Zhonghong Medical adheres to the principle of "safety first prevention foremost and comprehensive management." We
have developed a robust safety management network and implemented strategic plans including the Three-Year Action
6 Manager Senior (project) manager A Plan for Fundamental Work Safety Improvement (2024–2026) and the Occupational Disease Prevention and Control Plan
Grassroots Second level
5 Deputy manager Manager (Project) manager B and Implementation Program. These initiatives continuously enhance work safety measures raise employee awareness of
management engineer occupational health and foster a safe and healthy working environment.
4 Supervisor (Project) supervisor C
3 Senior staff A Impact Financial
Assistant Risk category Risk despcription Likelihood Response measures
2 Staff Mid-level staff B period impact
engineer
1 Junior staff C With increasingly stringent Regularly monitor updates to
regulations on work safety and relevant laws and regulations
Increased
Zhonghong Medical's "dual-channel" career development occupational health failure to identify maintain full-process records of Policy risk Low Short-term compliance
and implement the latest legal occupational health and safety
costs.requirements may result in regulatory management and conduct
penalties and legal liabilities. internal compliance audits.Occupational Health and Safety Improper employee operation or failure Conduct regular hazard
to correctly use personal protective
identification and risk
equipment in production workshops Increased
Occupational health and safety form the foundation for sustainable business development. Zhonghong Medical has established Operational inspections update emergency may lead to occupational diseases Low Short-term operating
a end-to-end occupational health management system to prevent occupational diseases monitor employee health and safety risk response plans enhance intrinsic mechanical injuries or hazardous gas costs.implement timely interventions. By promoting a strong safety culture we ensure the physical and mental well-being of safety measures and strengthen exposure causing occupational health
employees throughout the production process. During the reporting period no major safety incidents occurred. employee safety culture training.harm or production accidents.Governance Opportunity Impact Financial Opportunity description Likelihood Response measurescategory period impact
Intelligent upgrades will reduce Increase investment in digital
Zhonghong Medical strictly complies with Chinese laws and regulations including the Law on Work Safety the Fire Control Law the Improved
workplace injuries prevent and intelligent systems continue
Law on the Prevention and Control of Occupational Diseases the Regulations on the Safety Management of Hazardous Chemicals operational
Corporate occupational diseases improve upgrading automated equipment
and the Regulations on Occupational Health Supervision in Workplaces. We have obtained ISO 45001 certification for occupational efficiency
reputation production efficiency and stability Medium Long-term conduct comprehensive health
health and safety management and implemented internal management systems such as the Work Safety Management Measures and long-
opportunity protect employees' health and safety and safety training for all
Occupational Disease Prevention System and the Occupational Disease Hazard Warning and Notification System. In addition we term
and enhance the company’s public employees and strengthen daily
signed the 2025 safety responsibility agreement with all departments adopted a "dual responsibility per role" policy and incorporated profitability.image and reputation. safety compliance practices.the number of work injuries occupational diseases and safety accidents into management performance assessments.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report People-Centered Approach for Unity and Strength 48 49
Impact risk and opportunity management
Zhonghong Medical integrates occupational health and safety management closely with business operations. We conduct
regular hazard identification and risk assessments strengthen hazardous chemical management and systematically identify and
evaluate all potential risks. By preventing controlling and eliminating safety hazards and occupational health risks we safeguard
employees' health and rights.Risk assessment and control
We implement a dual-prevention mechanism regularly conducting comprehensive risk identification and
assessment. In accordance with the Risk Classification and Control Plan we apply differentiated management for
safety risks of varying levels intensifying the control of key security risks and improving intrinsic safety standards.We strengthen occupational health and safety risk identification and control by completing annual workplace Organizing safety culture training
occupational disease hazard assessments. We classify occupational disease hazards and risks compile a Job
Exposure to Occupational Disease List and improve protective measures in a targeted manner.Hazard inspection and mitigation Conducting safety emergency drills
W e follow the Safety Risk Control and Hazard Mitigation Manual regularly conduct safety and environmental
assessments and systematically inspect for safety hazards. Inspections before holidays during Work Safety Month
and routine work safety compliance checks will be arranged. We also implement preventive measures to close Metrics and targets
management loops. In 2025 nearly 100 safety issues were addressed and rectified.Targets Progress in 2025
Zero incidents of general level or above in work safety Achieved
Emergency management 100% compliance with safety risk assessment results Achieved
We have established a comprehensive emergency management system and developed both general and specialized Zero incidence of occupational diseases Achieved
contingency plans including the Comprehensive Emergency Plan Emergency Drill Plan for Environmental Incidents 100% coverage of safety training for all employees Achieved
and Emergency Response Manual for Special Equipment Accidents . We define governance structures and response
procedures and conduct regular emergency drills to enhance overall employee preparedness.In 2025
Occurrence rate of general Work-related fatalities Work-related fatality Invested in employee work-
Occupational health management level or above safety over the past three rate over the past related injury insurance
production accident years three years
A part from health check-ups for all employees and occupational health records we also organize the pre-job on- RMB 2.1929 million
the-job and post-job occupational health examinations for hazard-exposed positions. Meanwhile we improve 0% 0 0%
employee health awareness through occupational health education and occupational disease prevention campaigns.We have formulated the PPE Management Policy to ensure compliant distribution of standard and specialized Rate of dangerous operation Inspection rate of special Training rate of occupational health for workers exposed
protective gear while conducting regular inspections and maintenance of protective equipment. personnel holding relevant equipment and facilities to occupational hazards
certificates
100100%100%%
Safety culture development
Participants of the Total hours of employee safety Safety emergency Participants in safety drills
We develop an annual safety training plan and conduct at least one comprehensive safety training session across the employee safety training training drills
workforce. Training covers laws and regulations job-specific safety procedures and emergency response measures
cultivating a workplace culture where everyone prioritizes safety. 24655 53881.50 62 13860hours2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Responsibility First Guided by Our Original Mission 50 51
Responsibility First
Guided by Our
Original Mission
Zhonghong Medical upholds an open collaborative and
shared-responsibility approach deeply cultivating the industry while
giving back to society. Built on our strengths we strive to improve
access to healthcare coordinate upstream and downstream efforts
and promote high-quality development across the sector. By
delivering health with care we translate our responsibility into
tangible actions that benefit society and enhance people's
well-being collectively building a sustainable and healthy future.Material topics
Healthcare accessibility
Industry development
Support for community-based charity
Contributions to UN SDGs2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Responsibility First Guided by Our Original Mission 52 53
Healthcare Accessibility
Zhonghong Medical focuses on the protective needs of the healthcare industry and has established a comprehensive healthcare
We are driving the R&D and industrialization of multiple products including food-grade nitrile
accessibility management system. We optimize our product portfolio to become the most complete supplier of medical gloves Advancing new
gloves ultra-thin nitrile gloves and specialty nitrile gloves. A total of 10 new products have
in China. By leveraging technological innovation we enhance equitable access to healthcare aligning supply with the economic product development
been investigated across infusion lines and production lines.development market characteristics and healthcare levels of the regions where we operate. We also facilitate the distribution
of high-quality medical resources and have been recognized as a V-level client by the China Export & Credit Insurance Responding to volume- We actively participate in more than 11 national and provincial-level procurement projects
Corporation. We work hard to ensure that safe and efficient medical products and services reach a broader population. based procurement with over 10 products selected and more than 120 additional medical institutions served.Expanding product coverage We are building an integrated online-offline network with multiple tracks. SPD (Supply Innovating in channel Processing Distribution) partner hospitals now exceed 40 and we are expanding into
models emerging markets such as private healthcare and veterinary medicine establishing new
Zhonghong Medical continuously optimizes its global supply network and service collaborations with 15 private healthcare groups.infrastructure strengthening regional warehousing distribution and support systems to
enhance product accessibility and supply stability. Through diversified channels and innovative We have developed three product matrices: high-end innovative core profit-driving and basic Optimizing product
products and services we attract more potential customers and expand product reach essential products. For tertiary hospitals we launched four high-value new products tailored portfolio
delivering high-quality products to support global public health cause. to meet diverse market needs.Through refined supply chain management we maintain reasonable procurement costs while
Product accessibility Ensuring stable leveraging modern logistics technologies including IoT and big data analytics to improve
In 2025 ??个 supply and logistics transportation efficiency and ensure on-time safe delivery to customers.German Russian
Office Office
Products were sold in UK Office
Hungarian
Dutch Office
100 CompanyFrench + countries Office Focusing on specific needsGroup Headquarters
and regions including Spanish Tangshan Production Base
Office
North America Europe Shanghai Company Canadian Office Zhonghong Medical prioritizes the needs of key populations and diverse healthcare scenarios. Leveraging strong R&D
Tunisia Japanese
the Middle East Japan Guilin Office Mexican OfficeProduction Base Office capabilities we address domestic technological gaps in relevant fields and continually launch safe reliable practical efficient
Jiujiang Production Base
Yichun Production Base American Company
and Africa. Italian Office Hong Kong Kazakhstan Thailand Company and cost-effective medical devices.Jordanian Office Production Base Shenzhen Production Base
Office
Hainan
Company
3000 The production base in Brazilian OfficeSoutheast Asia is under construction Medispo protein non-detectable gloves Huadum high barrier condom+ Malaysian Office
domestic hospitals The gloves use the industry's advanced decomposition Featuring a threelayer protective Singaporean
Company Chile Office
including national and and detachment technology of protein to fully reduce structure it effectively prevents the
Argentinian Office
provincial benchmark allergens and lower risks for people allergic to latex. penetration and transmission of HIV.hospitals were newly
engaged or under stable Company / Office Medispo polyisoprene gloves
Production Base Long-life high-performance
collaboration. The gloves are made of ultra-soft polyisoprene extended nuclear protection gloves
and contain no natural rubber latex making them
Overseas clients Built with highly efficient nano-scale
Product portfolio suitable for people with latex allergies. nuclear radiation shielding materials
450 reinforced by a high-strength rubber approx. Health protection Safe infusion Innovative incubation Medispo KBD gloves matrix the gloves deliver outstanding
The gloves use the positive charge generation anti-permeation and chemical resistance.With subsidiaries established M edical examination Infusion sets I nfusion pumps
in Beijing Hong Kong (China) gloves Syringes Syringe pumps
technology to protect healthcare professionals
Medical surgical gloves Indwelling needles Nutrition pumps while reducing incision infections. They are suitable the United States and the
M edical radiation Blood collection tubes Medical sensor consumables for high-risk surgeries susceptible to infection.Long-life high-performance
20 neoprene glove box glovesprotection gloves Nasal oxygen cannula and lead wiresNetherlands and + Non-medical protective Sterilized connectors DS50 Series workstations Made from premium imported neoprene Medispo radiation protection gloves
offices worldwide the gloves Disposable nebulizers Digital temperature latex these gloves pose a minimal risk With high radiation protection performance
Company ranks among the Polyisoprene gloves … management solutions of allergic reactions and are suitable for the gloves are suitable for interventional and
world's top manufacturers Condoms D isposable medical harsh working environments involving diagnostic radiology procedures protecting
with an annual output of over Finger cots temperature sensors heavy oils strong acids and strong bases. healthcare professionals from radiation exposure.ten billion gloves. … …2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Responsibility First Guided by Our Original Mission 54 55
Reducing healthcare costs Industry association Membership
China Rubber Industry Association Chairman unit Chairman member of Latex Branch
Zhonghong Medical while ensuring product quality continuously reduces costs through process improvements and lean
management. This enables more primary-level healthcare institutions and price-sensitive users to access safe and reliable medical Chinese Chemical Society Member
products at affordable prices. By leveraging large-scale orders we drive supply chain integration and optimize production processes
effectively controlling overall operating costs. The average price of products selected for volume-based procurement has decreased Hebei Emergency Industry Alliance Vice chairman member
by approximately 40% significantly alleviating the purchasing burden on medical institutions and reducing economic pressure on Safety and Health Protection Products Committee of
patients. Considering overseas market conditions per capita income and local healthcare levels we set differentiated and reasonable MemberChina Textile Business Association
pricing aligned with regional development. We actively participate in local government tenders gradually improving health awareness
in emerging markets and developing countries through affordable product pricing. Malaysian Rubber Glove Manufacturers Association
Member
(MARGMA)
Promoting health awareness
Zhonghong Medical guided by its responsibility within the healthcare industry actively participates in academic exchanges and Integrating industry and education to foster sustainable innovation
professional forums sharing practical achievements and engaging in in-depth discussions with industry experts and researchers.Based on our official website social media and other public communication platforms we continuously disseminate health To strengthen the talent foundation and empower long-term development Zhonghong Medical actively builds
knowledge and promote the proper use of medical devices. We integrate health-focused public initiatives with professional university-enterprise cooperation platforms. We have established deep collaborative relationships with organizations
services conducting diversified health education and community outreach programs. In collaboration with authoritative such as Shenzhen Technology University and Shenzhen Polytechnic exploring an innovative "industry-education-
academic institutions and medical associations we provide specialized training for doctors in key clinical departments helping research" model. By integrating academic intellectual resources with real-world corporate practice we facilitate
improve public health literacy and the service capabilities of healthcare professionals. seamless connections between theoretical research technological R&D and industrial application. This approach
creates a talent pool precisely aligned with industry needs continuously enhancing our capacity for technological
In 2025 problem-solving and innovation.Posts per month on WeChat Posts per month on WeChat Covering diverse health knowledge including
Official Account Channels the safe use of medical devices general
15+ 3+ healthcare knowledge physical health nasal health allergy tips and body protection. Zhonghong Kelun and Yichun University co-create an industry-education-research practice base
In October 2025 Zhonghong Kelun officially launched the Yichun University Teaching Practice Base initiating
Win-Win Collaboration comprehensive collaboration in talent development and technological innovation. Currently four PhD students are based at Zhonghong Kelun working on optimizing existing products applying and developing new materials and co-
developing new products. This collaboration effectively links university research outcomes with real corporate needs
accelerating the industrial application of innovative technologies.Zhonghong Medical adheres to an open collaborative and mutually beneficial development philosophy actively building a multi-
faceted industrial ecosystem. We deepen industry–academia–research cooperation to integrate scientific research outcomes
with industrial practice. Through participation in domestic and international industry exhibitions we strengthen exchanges with
supply chain partners customers and industry institutions expanding collaboration opportunities and sharing development
benefits. The Company also contributes to the development of industry standards using practical experience to support the Social Welfare Engagement
improvement of standard systems thereby promoting standardization and high-quality development in the healthcare sector.Guided by the core principle of "Protecting Health Giving Back to Society" Zhonghong Medical actively fulfills its corporate
social responsibility and deeply integrates into local community development. Through volunteer services cultural initiatives
and targeted support programs we build bridges for positive interaction with the community contributing to an inclusive
We organized or participated in nearly 50 domestic and international exhibitions academic conferences and brand caring and sustainable social ecosystem.events reaching 3000+ customers.We led the drafting of the industry standard Norm of Energy Consumption Per Unit Production of Latex Products
which was submitted to the China Rubber Industry Association for public consultation. Guilin HBM: Volunteer service lights up the reading room
We participated in the formulation of voluntary national standards Natural Rubber Latex Cleanroom Gloves Nitrile
Cleanroom Gloves Single-use Rubber Gloves for General Applications and the obligatory national standard
Medical Gloves Safety Technology Requirements . To promote the spirit of volunteerism and cultivate a positive corporate culture Guilin HBM actively carries out
volunteer activities to support the development of staff reading rooms. These initiatives enrich employees' cultural
As a principal drafting organization MedRena participated in developing the industry association group standard and intellectual life while fostering a sense of mutual assistance and social responsibility.Infusion Information Collection System.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sound Governance for Honest Operations 56 57
Sound Governance
for Honest
Operations
Sound corporate governance forms the foundation for sustainable
growth and serves as the core support for navigating complex
market landscapes and aligning stakeholder interests. Zhonghong
Medical consistently upholds integrity compliance and business
ethics continuously optimizing its governance system and
organizational structure. The Company strengthens internal controls
and risk management enhances operational transparency and
accountability and safeguards high-quality growth through standard
and efficient governance practices.Material topics
Corporate governance
Investor relations management
Operational compliance
Business ethics and anti-corruption
Information security
Contributions to UN SDGs2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sound Governance for Honest Operations 58 59
Governance Foundation In 2025 Average tenure of Board members Standard deviation of the ages of directors and senior management
4.14 years 8.33 years
Zhonghong Medical strictly adheres to Chinese laws and regulations including the Company Law Securities Law Code of
Corporate Governance for Listed Companies and the Rules Governing the Listing of Shares on the ChiNext Market of Shenzhen
Stock Exchange. Accordingly we work to build a transparent responsible and efficient modern governance mechanism to
Board meetings convened Director attendance rate
continuously enhance the effectiveness of corporate governance.
10100%
Corporate governance
Strategy and Sustainability Remuneration Appraisal and Nomination Audit Committee meetings
In accordance with internal regulations such as the Articles of Association the Rules of Procedure for the Shareholders' Meeting Committee meetings convened Committee meetings convened convened
and the Rules of Procedure for the Board of Directors Zhonghong Medical continues to refine supporting rules including the Rules
of Procedure for Board Committees and the Management Measures for Controlling Subsidiaries . In line with the newly revised 3 5 12
Company Law the Company prudently abolished the Board of Supervisors with its supervisory functions fully assumed by the Audit
Committee of the Board. The Company maintains a governance structure centered on the Shareholders' Meeting the Board of
Directors and management. The Shareholders' Meeting serves as the highest authority the Board acts as the core governance body All meetings were in compliance with the Rules Governing the Listing of Shares on the ChiNext Market of Shenzhen Stock
and regularly reports to the Shareholders' Meeting while the management is responsible for day-to-day operations with clearly Exchange and the rules of procedure within their scope of authority.defined responsibilities among all parties and coordinated operations. Specialized committees under the Board including the Strategy
and Sustainability Committee the Audit Committee and the Remuneration Appraisal and Nomination Committee coordinate key
internal functions such as strategic decision-making audit oversight and sustainability management. In 2025 the Board reviewed and
approved matters including overseas greenfield and M&A projects related-party transactions senior executive remuneration plans IR management
and the abolition of the Board of Supervisors contributing to a stronger internal governance system.The Board comprises nine members including three independent directors and one female director. Director selection takes Zhonghong Medical continues to strengthen information disclosure and investor relations In 2025
into account diverse factors such as age gender educational background and profession. Board members possess extensive (IR) management by revising policies such as the Information Disclosure Management Reports announcements and other
experience in areas including industry operations financial auditing laws and regulations and corporate management. They System and the Investor Relations Management System. The Company standardizes documents issued on Shenzhen Stock
possess the professional knowledge and comprehensive capabilities required to fulfill their duties. The Company has revised the disclosure of financial and non-financial information including strategic initiatives Exchange
the Rules for the Special Meeting of Independent Directors regularly assesses and reports on Board independence and further material matters operational developments and financial performance to enhance our
improves support mechanisms to ensure that independent directors effectively perform their duties. All directors attend relevant transparency. Through brokerage strategy meetings roadshows and earnings briefings
meetings in accordance with regulatory requirements and regularly participate in training on laws regulations and compliance. the Company deeply engages in the communication with institutional investors. We also 193
They exercise their powers prudently and perform their duties in a standardized manner. The composition and qualifications of regularly answer investor hotline calls and respond to inquiries on platforms maintaining
the Board fully comply with applicable laws regulations and the Articles of Association. efficient communication with both individual and institutional investors safeguarding the
rights to information and returns of all shareholders particularly minority shareholders.Shareholders' Meeting
Strategy and Sustainability Committee Operational Compliance
Board of Directors Remuneration Appraisal and Nomination Committee
Zhonghong Medical steadfastly upholds law-based governance and a prudent operational strategy embedding legal
Audit Committee compliance and risk prevention throughout its operations. In response to evolving regulatory and environmental landscapes we
The Management continuously refine our compliance systems and working mechanisms. By strengthening risk management and internal controls
we strive to drive high-quality corporate development.Zhonghong Medical governance structure
Compliance internal control and risk management
Extended reading
Zhonghong Medical consistently regards compliant operations as a fundamental principle. Through a coordinated model of
For more governance and financial information please refer to: Zhonghong Medical Annual Report 2025 or our “institutional support audit oversight and cultural empowerment” we have built a fullprocess compliance loop covering
official website (https://www.zhonghongmedical.com/list-49-1.html). prevention control and post-event optimization to strengthen risk management and internal controls. This integrated approach
establishes a solid compliance foundation that supports highquality development.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sound Governance for Honest Operations 60 61
R evised the Guidelines on Compliance Risk Management clarified the division of responsibilities and work
procedures of all levels in compliance management established a normalized and institutionalized compliance Business Ethics
operation mechanism and improved management efficiency.Emphasized the operation of the Compliance Committee promoted the appointment of Chief Compliance
Officers and gave play to the role of compliance administrators in all departments and affiliated enterprises. Zhonghong Medical upholds business ethics and operates with integrity and compliance. The Company strictly prevents
Compliance I ntegrated compliance review as a mandatory procedure into the operation and management process regularly corruption and commercial bribery firmly opposes unfair competition and strengthens information security. Built on end-to-
management evaluated compliance management work and promoted the continuous improvement and effective operation end risk prevention and control mechanisms and standardized operations we safeguard market order and protect the legitimate
system of the compliance management system. rights and interests of the Company and our stakeholders.Organized 4 special training sessions on law and compliance and carried out various publicity and
implementation activities to enhance the legal and compliance awareness of all employees.Improved and perfected the internal control system issued the Internal Control Manual (2025 Edition) and Anti-corruption
2 volumes of Internal Control Manual (Sub-volume) for merged and acquired enterprises ensuring that the
manual content matches business reality and regulatory requirements.Optimized core business processes streamlined approval links clarified the responsibility boundaries and operation Zhonghong Medical strictly complies with laws and regulations on anti-corruption and anti-bribery. In accordance with policies
standards of each post strengthened process time limit management and improved execution efficiency. such as the Employee Code of Professional Ethics and the Integrity Risk Prevention Manual the Company communicates its
Internal Gave play to the supervision role of internal audit completed 8 internal audit projects throughout the year zero-tolerance stance on corruption to employees and business partners. Internally all employees are required to sign integrity
control accepted 5 external audits and inspections included rectification items in the performance of persons in commitments. Through internal communications integrity reminders and warning education the Company continuously
system charge and achieved a 100% completion rate of rectification items within a time limit. reinforces anticorruption awareness. Externally all procurement personnel sign the Integrity Commitment Letter and business
Solidified internal control supervision and evaluation organized internal control self-evaluation of the partners sign the Integrity Agreement. These measures strengthen integrity risk control in key areas such as procurement and
headquarters and 23 affiliated enterprises and achieved full coverage of the self-evaluation scope. sales and prevent misconduct including corruption embezzlement and bribery.Launched the optimization of the risk management system improved the basic risk management framework The Company has established
with clear rights and responsibilities smooth processes comprehensive coverage and unified standards and public reporting email and hotline Reporting email: tsjb@zhonghongpulin.cn
significantly improved the speed and accuracy of risk identification assessment and response. channels—including email letters
Strengthened the response to major risks formulated more accurate effective and company-preference- and inperson reporting—to enable
Reporting hotline: 0315-4169049
compliant major risk response strategies and enhanced the proactive management capability and decision- customers employees and
making level for major risks. suppliers to report misconduct. We
Risk Updated risk monitoring indicators and early warning rules formulated the Risk Monitoring Indicator Library commit to strictly protecting the
management and quantitatively judged standards by checking the early warning rules and critical values of each indicator to confidentiality of whistleblowers
system ensure that the early warning threshold range is closed and covers all scenarios. and reported information. All reports
Carried out in-depth risk assessment monitoring and comprehensive risk analysis held regular meetings of the are investigated in accordance
risk management working group dynamically evaluated risk impacts and promoted the practical improvement with established procedures
of risk prevention and resolution capabilities. with zero tolerance for shielding
any individual or misconduct.Any unauthorized disclosure of
IPR protection information or retaliation against whistleblowers will be addressed
in accordance with applicable
Zhonghong Medical regards intellectual property rights (IPRs) as the key to technological innovation and core competitiveness. The Company laws and regulations.strictly complies with Chinese laws and regulations including the Patent Law and Trademark Law and has established a comprehensive
end-to-end IPR management system. IPR management is integrated into all stages of R&D production and operations with mechanisms in Warning education
place for patent identification application and protection. The Company strengthens IPR risk prevention standardizes trademark usage and
trade secret protection and regularly conducts IPR training covering all roles in R&D production and marketing reinforcing company-wide
IPR compliance and awareness. During the reporting period the Company encountered no major IPR infringement or conflict cases.In 2025 Anti-unfair competition
Invention patents Utility model patents 2025 Jointly formulated standards The Company upholds compliant operations and explicitly prohibits unfair competition practices such as false advertising
4 5 S afety Technical Requirements for Medical Gloves (GB 24788-2025) abuse of power commercial bribery and infringement of trade secrets. We have established a full-process mechanism covering N itrile Cleanroom Gloves (GB/T 46165-2025) risk identification violation handling and accountability. In market competition we respect competitors and refrain from
Natural Rubber Latex Cleanroom Gloves (GB/T 46166-2025) disseminating false information that could damage their reputation through social media news outlets or other channels
Design patents applied Academic papers published Single-use Rubber Gloves for General Applications (GB/T 46059-2025) thereby safeguarding a fair business environment and the legitimate rights of market players. In 2025 the Company had no
1 3 Norm of Energy Consumption per Unit Production of Latex Products (T/CRIA) litigation cases or administrative penalties arising from unfair competition.2025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Sound Governance for Honest Operations 62 63
Key Performance Table
Fair competition Regular risk inspection
We improved the compliance review mechanism for We regularly conducted risk inspections related to unfair
marketing activities. All marketing plans promotional competition focusing on key areas such as sales bidding Economic
materials and bidding documents were reviewed and and promotion. We maintained risk inspection records
approved by the Legal Department prior to release or and promptly implemented corrective measures forming Indicator Unit 2024 2025
submission to ensure compliance. a closed-loop management process across inspection
Revenue RMB million 2456.6507 2373.2068
rectification and review.Total assets RMB million 7230.3608 7437.7981
Owner's equity RMB million 5620.6856 5421.6962
Business secret protection Compliance awareness
Total profit RMB million -66.9034 -124.1092
We clearly defined the scope of trade secrets signed We regularly conducted training on anti-unfair competition Net profit RMB million -85.8304 -116.4773
confidentiality agreements with key employees strengthened using case studies and compliance interpretations to educate
security of office environments and information systems and employees on relevant laws and regulations enhancing Net profit attributable to shareholders of the parent company RMB million -87.1289 -112.3832
standardized handover procedures for departing employees compliance awareness across the workforce.to prevent the leakage of trade secrets. Environmental
Indicator Unit 2024 2025
Total environmental investment RMB 10000 1008.82 2257.33
Information security Total GHG emissions tCO2e 818075.31 851780.57
Scope 1 GHG emissions tCO2e 9453.28 3206.49
Zhonghong Medical is certified to ISO 27001 Information security management systems. We continuously optimize our system Scope 2 GHG emissions tCO2e 808622.03 848574.08
through training and communication implementation audit-based supervision and continuous improvement. Our annual
GHG emission intensity tCO e/RMB 10000 3.3300 3.5892
information security training and cybersecurity emergency drills cover all employees enhancing their awareness and incident 2
response capabilities. We have also established the Security Operations Center (SOC) with such security equipment in place Total wastewater discharged m3 2553541.44 2792250.90
as firewalls intrusion detection systems and vulnerability scanning tools. Through routine inspections regular vulnerability
3
scanning and remediation and biannual special audits we endeavor to build a robust information security protection system. In Total industrial wastewater m 2330200.54 2519299.21
2025 no information security accidents occurred.
Total domestic wastewater m3 223340.90 272951.69
The Company respects and protects the privacy of its stakeholders. The data collection retention processing and sharing are Total waste ton 3041.05 2965.35
conducted with the informed consent of relevant parties and all data sources are legally compliant. Measures such as data
encryption off-site backup and access control are implemented to secure safety management throughout data lifecycle. Total hazardous waste ton 1276.65 764.43
Intensity of hazardous waste ton/RMB 10000 0.0052 0.0032
Total non-hazardous waste ton 1764.40 2200.92
Internal audit We conducted a special information security audit covering all critical information systems and timely rectified 8 identified issues. Intensity of non-hazardous waste ton/RMB 10000 0.0072 0.0093
Coal consumption ton 1619.48 0.00
We organized 4 company-wide information security training sessions on topics such as basic Gasoline consumption L 6578.66 23514.98
Awareness cybersecurity knowledge phishing email recognition malware prevention and data protection Diesel consumption L 59997.43 61129.77
training practices.
3
We held the “Cybersecurity Week” campaign in forms of posters case sharing and knowledge Natural gas consumption m 346615.00 110630.45
competitions to raise employees’ cybersecurity awareness.Consumption of coke oven gas m3 6026192.00 3203744.00
Purchased electricity MWh 363324.69 398951.91
Emergency We conducted a data breach emergency drill where we simulated the data leakage emergency of core Steam consumption ton 2019403.85 2138596.71
drill customers and optimized our emergency response plans based on issues identified during the exercise.Direct energy consumption tce 5401.93 2217.062025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Key Performance Table 64 65
Environmental Social
Indicator Unit 2024 2025 Indicator Unit 2024 2025
Indirect energy consumption tce 242501.18 255436.15 Participants in volunteer activities headcount - 13
Total energy consumption tce 247903.11 257653.20 Hours of volunteer activities hour - 26
Energy intensity tce/RMB 10000 1.0091 1.0857 Total tax payment RMB million 46.7684 54.0523
Clean energy usage MWh 3751.00 1197.22 Total number of suppliers - 958 934
Packaging materials used ton 18533.02 13643.71 Percentage of products withdrawn and recalled due to health and safety reasons % 0 0
Total water consumption ton 2541786.74 2941536.94 Customer complaints time - 306
Domestic water consumption ton 304806.94 295803.64 Customer complaint resolution rate % 100 100
Industrial water consumption ton 2236979.80 2645733.30 R&D investment RMB million 98.3142 113.1865
Water resource utilization intensity ton/RMB 10000 10.3466 12.3948 Proportion of total R&D investment to main business revenue % 4.00 4.77
Social R&D personnel headcount 516 625
Indicator Unit 2024 2025 Proportion of R&D personnel % 12.20 16.09
Total employees headcount 4228 3884 Total invention patents - 63 64
Male headcount 1443 1378 Number of invention patent applications - 10 4
Female headcount 2785 2506 Number of authorized invention patents - 12 14
< 30 years old headcount 444 389 Number of valid patents - 225 240
30-50 years old headcount 3473 3129 Governance
> 50 years old headcount 311 366 Indicator Unit 2024 2025
Number of dispatched employees headcount 39 32 Total directors headcount 9 9
Employees from ethnic minorities headcount 173 208 Total female directors headcount 2 1
Number of employees with disabilities headcount - 44 Total independent directors headcount 3 3
Total employee turnover rate % - 29.05 Stock pledge ratio % 0 0
Shareholders' Meetings held time 4 5
Investment in work-related injury insurance for employees RMB million 1.9895 2.1929
Announcements and reports etc. released on the exchanges - 155 193
Coverage rate of work-related injury insurance % 97.28 93.77
Amounts involved in data security incidents RMB million 0 0
Work-related fatalities headcount 0 0
Number of major litigation arbitration and other risk events involved - 0 0
Work-related fatality rate % 0 0
Number of violations and total fines paid RMB 0 0
Employee training expenditure RMB 224800 229800
Directors trained in anti-commercial bribery and anti-corruption headcount 9 9
Employee training sessions time 403 432 Percentage of directors trained in anti-commercial bribery and anti-corruption % 100 100
Total employees trained headcount 2826 2321 Management personnel trained in anti-commercial bribery and anti-corruption headcount 30 32
Employee training coverage rate % 66.84 59.76 Percentage of management personnel trained in anti-commercial bribery and
%100100
anti-corruption
Average hours of training per year per employee hour 4.68 7.55
Employees trained in anti-commercial bribery and anti-corruption headcount 4228 3884
Percentage of employees receiving regular performance and
%-41.92
career development reviews Percentage of employees trained in anti-commercial bribery and anti-corruption % 100 1002025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Indicator Indexes 66 67
Indicator Indexes GRI Standard Disclosures Page/remark
2-24 Embedding policy commitments 59
2-25 Processes to remediate negative impacts 34-39、44
GRI Content Index 2-26 Mechanisms for seeking advice and raising concerns 44
GRI 2：
General disclosures 2-27 Compliance with laws and regulations 59-62
2021
2-28 Membership associations 55
Zhonghong Medical has prepared this report in accordance with the GRI Standards for the period from
Statement of use
January 1 2025 to December 31 2025. 2-29 Approach to stakeholder engagement 12-13
GRI 1 used 2-30 Collective bargaining agreements 44GRI 1: Foundation 2021
GRI 3: 3-1 Process to determine material topics 11-12
Material Topics 2021
GRI Standard Disclosures Page/remark 3-2 List of material topics 12
2-1 Organizational details 6 Economic
2-2 Entities included in the organization’s sustainability reporting 1 GRI 204 Procurement
3-3 Management of material topics 34-36
Practices 2016 204-1 Proportion of spending on local suppliers 36
2-3 Reporting period frequency and contact point 1
3-3 Management of material topics 61
No restatements of information during
2-4 Restatements of information
the reporting period 205-1 Operations assessed for risks related to corruption 61
GRI 205 Anti-
2-5 External assurance Incomplete (data to be collected) corruption 2016 205-2 Communication and training about anti-corruption policies 61
and procedures
2-6 Activities value chain and other business relationships 6-8、34-39
205-3 Confirmed incidents of corruption and actions taken 61
2-7 Employees 42-43
GRI 206 Anti- 3-3 Management of material topics 61-622-8 Workers who are not employees 42-43
competitive Behavior 206-1 Legal actions for anti-competitive behavior anti-trust and
2-9 Governance structure and composition 58 2016 61monopoly practices
2-10 Nomination and selection of the highest governance body 58 Environmental
GRI 2： 2-11 Chair of the highest governance body 58 3-3 Management of material topics 23
General
2-12 Role of the highest governance body in overseeing the
disclosures 58 GRI 301 Materials 301-1 Materials used by weight or volume 23management of impacts
2021 2016 301-2 Recycled input materials used Incomplete (data to be collected)
2-13 Delegation of responsibility for managing impacts 58
301-3 Reclaimed products and their packaging materials 23
2-14 Role of the highest governance body in sustainability reporting 10
3-3 Management of material topics 22
2-15 Conflicts of interest For details see the 2025 Annual Report
302-1 Energy consumption within the organization 63-64
2-16 Communication of critical concerns 58
302-2 Energy consumption outside of the organization Incomplete (data to be collected)
2-17 Collective knowledge of the highest governance body 58 GRI 302 Energy 2016
302-3 Energy intensity 64
2-18 Evaluation of the performance of the highest governance body 58
302-4 Reduction of energy consumption 22
2-19 Remuneration policies 58
302-5 Reductions in energy requirements of products and services 20、22
2-20 Process to determine remuneration 58
3-3 Management of material topics 23-24
2-21 Annual total compensation ratio Confidentiality restrictions (trade secrets) GRI 303: Water and
303-1 Interactions with water as a shared resource 23-24
2-22 Statement on sustainable development strategy 4 Effluents 2018
303-2 Management of water discharge-related impacts 23-24
2-23 Policy commitments 15、20、28、32、472025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Indicator Indexes 68 69
GRI Standard Disclosures Page/remark GRI Standard Disclosures Page/remark
303-3 Water withdrawal 23 403-7 Prevention and mitigation of occupational health and safety impacts
GRI 303: Water 47-48GRI 403: directly linked by business relationships
and Effluents 303-4 Water discharge 24、63 Occupational 403-8 Workers covered by an occupational health and safety management system 46-47
2018
303-5 Water consumption 23、64 Health and
Safety 2018 403-9 Work-related injuries 49
3-3 Management of material topics 22 403-10 Work-related ill health 48
305-1 Direct (Scope 1) GHG emissions 23、63 3-3 Management of material topics 45
305-2 Energy indirect (Scope 2) GHG emissions 23、63 GRI 404: Training 404-1 Average hours of training per year per employee 65
and Education 404-2 Programs for upgrading employee skills and transition assistance programs 45
305-3 Other indirect (Scope 3) GHG emissions Incomplete (data to be collected) 2016
GRI 305: 404-3 Percentage of employees receiving regular performance and career 65
Emissions 2016 305-4 GHG emissions intensity 23、63 development reviews
305-5 Reduction of GHG emissions Incomplete (data to be collected) GRI 405: 3-3 Management of material topics 42-43
Diversity
305-6 Emissions of ozone-depleting substances (ODS) N/A (No ODS emissions) 405-1 Diversity of governance bodies and employees 42-43and Equal
Opportunity Confidentiality restrictions
305-7 Nitrogen oxides (NOx) sulfur oxides (SOx) and other significant air For details see the 2025 Annual 405-2 Ratio of basic salary and remuneration of women to men
2016 (trade secrets)
emissions Report
GRI 406: Non- 3-3 Management of material topics 43
3-3 Management of material topics 24 discrimination
2016 406-1 Incidents of discrimination and corrective actions taken None306-1 Waste generation and significant waste-related impacts 24
GRI 408: Child 3-3 Management of material topics 42
GRI 306: 306-2 Management of significant waste-related impacts 24 Labor 2016
Waste 2020 408-1 Operations and suppliers at significant risk for incidents of child labor None306-3 Waste generated 24、63
GRI 409: Forced 3-3 Management of material topics 43
306-4 Waste diverted from disposal 24、63 or Compulsory 409-1 Operations and suppliers at significant risk for incidents of forced or
Labor 2016 None
306-5 Waste directed to disposal 24、63 compulsory labor
3-3 Management of material topics 55
3-3 Management of material topics 35
GRI 308: Supplier GRI 413: Local 413-1 Operations with local community engagement impact assessments
Environmental 308-1 New suppliers that were screened using environmental criteria 35 Communities 55and development programs
Assessment 2016 2016
308-2 Negative environmental impacts in the supply chain and actions taken 35-36 413-2 Operations with significant actual and potential negative impacts on 55
local communities
Social GRI 414: 3-3 Management of material topics 35
3-3 Management of material topics 42 Supplier Social 414-1 New suppliers that were screened using social criteria 35
Assessment
GRI 401: 401-1 New employee hires and employee turnover 42 2016 414-2 Negative social impacts in the supply chain and actions taken 35-36
Employment 401-2 Benefits provided to full-time employees that are not provided to 3-3 Management of material topics 37
2016 44temporary or part-time employees GRI 416: 416-1 Assessment of the health and safety impacts of product and service
Customer Health 37
401-3 Parental leave 44 categories
and Safety 2016 416-2 Incidents of non-compliance concerning the health and safety
3-3 Management of material topics 46-48 Noneimpacts of products and services
403-1 Occupational health and safety management system 46-47 3-3 Management of material topics 39
403-2 Hazard identification risk assessment and incident investigation 48 GRI 417: 417-1 Requirements for product and service information and labeling 39
GRI 403: Marketing and 417-2 Incidents of non-compliance concerning product and service
Occupational 403-3 Occupational health services 48-49 Labeling 2016 Noneinformation and labeling
Health and
Safety 2018 403-4 Worker participation consultation and communication on 417-3 Incidents of non-compliance concerning marketing communications None48
occupational health and safety
GRI 418: 3-3 Management of material topics 38
403-5 Worker training on occupational health and safety 48-49 Customer 418-1 Substantiated complaints concerning breaches of customer privacy and
Privacy 2016 Nonelosses of customer data
403-6 Promotion of worker health 48-492025 Zhonghong Pulin Medical Products Co. Ltd. Sustainability (ESG) Report Indicator Indexes 70 71
Content Index of the Self-Regulatory Guidelines
No. 17 for Companies Listed on Shenzhen Stock
Exchange—Sustainability Report (For Trial
Implementation)
Dimension No. Topics Corresponding terms Page
1 Climate response Article 21-28 23
2 Pollutant discharge Article 30 24
3 Waste disposal Article 31 24
4 Ecosystem and biodiversity protection Article 32 N/A
Environmental
5 Environmental compliance management Article 33 20-21
6 Energy utilization Article 35 22
7 Water resources utilization Article 36 23
8 Circular economy Article 37 23、25
9 Rural revitalization Article 39 N/A
10 Social contributions Article 40 52-55
11 Innovation Article 42 28-30
12 Ethics of science and technology Article 43 N/A
Social 13 Supply chain security Article 45 34-36
14 Equal treatment of SMEs Article 46 58
15 Product and service safety and quality Article 47 31-33、37-39
16 Data security and customer privacy Article 48 14-17、38
17 Employees Article 50 42-49
18 Due diligence Article 52 34-35、59-60
Sustainability- 19 Stakeholder engagement Article 53 12-13
related
governance 20 Anti-commercial bribery and anti-corruption Article 55 61
21 Fair competition Article 56 61-62This report is printed on environmentally friendly paper.
Address:Southwest of the intersection of Zhongdajie and Jinxiu Road Luannan
Economic Development Zone Tangshan City Hebei Province China.Zip code: 063500
沪公网安备31011802005267号
